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Abstract
For their huge variety of functions mesenchymal stromal/stem cells (MSCs) are at-
tractive candidates for tissue engineering and cell therapy. Although in vitro differen-
tiation of MSCs is well established and has been extensively studied, little is known
about stem cell niches. So how are these niches defined in tissues and which cell-matrix
contacts determine the fate of MSCs therein? To approach this task, herein the adhe-
sive behavior of MSCs was evaluated under varying conditions employing non-invasive
impedance monitoring in real-time, using fibroblast and keratinocytes as non-specific
controls. Major focus was on changes in adhesion and migration of MSCs induced to
differentiate into adipogenic and osteogenic lineages, the effects of extracellular matrix
(ECM) contacts on this response, and the correlation of impedance profiles with specific
differentiation markers including the predictive value of these recorded profiles. Finally,
the influence of the MSC source was evaluated by comparing different cell populations
derived from bone marrow and fat tissue.
MSCs roughly resembled fibroblast adhesion while keratinocytes differed significantly,
which was reflected by impedance recordings. Inducing differentiation, impedance pro-
files of MSCs driven into the osteogenic lineage revealed a continuous rise of impedance
due to matrix deposition and strong cell-matrix contacts and furthermore by matura-
tion and formation of a mineralized matrix. Adipogenic differentiation was marked by
shallower initial slopes and eventually declining profiles, corresponding to more com-
pact and roundish cells with lowered cell-cell contacts. Concordance of impedance
profiles and differentiation markers of the varying differentiation potential of MSCs
from different donor and age underlined the reliability of the system. MSC migration
was delayed during adipogenesis or by increasing cell attachment in response to TNFα
treatment. Pre-coating with ECM proteins revealed favored osteogenesis on collagen I
and IV, whereas adipogenesis was increased on fibronectin, which was also reflected by
impedance recordings.
Overall, the present thesis revealed distinct differences of cell attachment during the
process of differentiation and the guidance of differentiation by cell-matrix contacts and
evaluated the potential of impedance measurements as a valuable tool for real-time,
non-invasive high throughput screening of cell properties and identification of receptors
involved in the regulation differentiation processes.
Zusammenfassung
Aufgrund ihrer vielfältigen Funktionen sind mesenchymale Stammzellen (MSCs) in-
teressant für die künstliche Gewebskonstruktion und die Zelltherapie. Obwohl die in
vitro Differenzierung von MSCs gut etabliert und weitreichend untersucht wurde, ist
wenig bekannt über die Stammzellnischen. Wie sind diese Nischen im Gewebe definiert
und welche Matrix-Kontakte bestimmen das Schicksal der MSCs? Um dieser Frage
nachzugehen wurde das Adhäsionsverhalten von MSCs unter verschiedensten Bedin-
gungen mit Hilfe von Impedanz-Messungen untersucht. Fibroblasten und Keratinozyten
dienten als unspezifische Kontrollen. Das Hauptaugenmerk lag auf den Veränderungen
der Zelladhäsion und Migration während der Differenzierung in Fett- oder Knochen-
Zelllinien, den Effekten von extrazellulären Matrix (EZM)-Kontakten auf diese Verän-
derungen und der Korrelation der Impedanz-Profile mit spezifischen Differenzierungs-
markern, bzw. wie diese Profile der Abschätzung der Differenzierung dienen können.
Desweiteren wurden Zellen aus Knochen- und Fettgewebe verglichen um den Einfluss der
Zellherkunft zu untersuchen. Während sich Keratinozyten klar unterschieden, stimmte
die Adhäsion von MSCs im Wesentlichen mit dem Verhalten von Fibroblasten überein,
was sich auch in Impedanz-Messungen widerspiegelte. Nach Induktion wiesen die Pro-
file der osteogenen Differenzierung aufgrund von Reifung und Bildung einer mineral-
isierten Matrix und starken Zell-Matrix-Kontakten einen kontinuierlichen Anstieg der
Impedanz auf. Adipogenese zeichnete sich durch anfänglich schwächere Steigung und
später abfallende Profile aus. Dies deckte sich mit kompakteren und runden Zellen sowie
geringeren Zell-Zell-Kontakten. Übereinstimmende Impedanzprofile mit dem Differen-
zierungsgrad der Zellen aus unterschiedlichen Spendern und unterschiedlichem Alter
bestätigen diesen Ansatz. Migration von MSCs konnte durch Induktion der Adipo-
genese oder durch Verstärkung der Zellanheftung durch TNFα-Behandlung verzögert
werden. Zellinteraktionen mit EZM-Proteinen zeigten, dass die Osteogenese auf Kolla-
gen I und IV bevorzugt wird, wohingegen die Adipogenese auf Fibronektin erhöht war.
Diese Ergebnisse konnten durch Impedanzmessungen bestätigt werden.
Die vorliegende Arbeit zeigt wesentliche Unterschiede der Zellanheftung während des
Verlaufs und die Steuerung der Differenzierung durch Zell-Matrix-Kontakte auf und
untersuchte die Möglichkeiten von Impedanz zur nicht-invasiven Hochdurchsatzbestim-
mung von Zelleigenschaften in Echtzeit und zur Identifizierung von Rezeptoren die an
der Regulierung der Abläufe der Differenzierung beteiligt sind.
Für meinen Papa.
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1 Introduction
1.1 Mesenchymal stromal cells
Since their first description by Friedenstein et al. in 1970, mesenchymal stromal/stem
cells (MSCs) have evolved from connective-tissue generating cells to a promising resource
for therapeutic applications. Their adaptive mesodermal differentiation potential, im-
mune regulatory properties and trophic functions make MSCs attractive candidates for
novel cell therapies (Kern et al., 2006; Sensebé et al., 2010; Zhao et al., 2010). By
selecting adhesive stromal cells, MSCs are readily isolated from various human tissues,
including bone marrow and adipose tissue. They can be propagated in vitro maintain-
ing their differentiation capacity and genetic stability (Kern et al., 2006; Bieback et al.,
2009), though clonal nature defined as CFU-Fs (colony forming unit-fibroblastic cells)
and true multipotent stemness are questionable in some cases (Bianco et al., 2010).
Function and MSC behavior depend on the tissue of origin, age and individual charac-
teristics of the donor, but also conditions of isolation and early propagation (Kern et al.,
2006; Bieback et al., 2009; Gregory et al., 2005), all of which have to be addressed to
qualify MSC isolates. Strategies to yield more homogeneous populations e.g. by clonal
amplification or cell sorting are often hampered by paucity of suitable well-defined sur-
face markers allowing for prospective isolation. Very crucial for expansion of MSCs is
maintenance of stemness, i.e. self renewal capacity and specific tissue precursor proper-
ties, as prerequisites for clinical application. As promising approach for extending life
span in vitro hTERT has been inserted in MSCs (Hung et al., 2010), which could foster
tissue engineering but may in vivo increase the risk for developing cancer.
To provide common standards in the field of MSCmore homogeneous, the International
Society for Cellular Therapy (ISCT) defined minimal criteria for these cells. Accord-
ing to these criteria, MSCs must be (1) multipotential in vitro i.e. they must be able
to differentiate at least into adipogenic, osteogenic and chondrogenic lineages and (2)
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plastic-adherent. Additionally, surface markers of MSCs were defined and accordingly
(3) MSCs must express CD105, CD73 and CD90. For excluding contamination, mainly
by several types of hematopoietic cells, (4) they should lack CD45, CD34, CD14 or
CD11b, CD79α or CD19 and HLA-DR (Dominici et al., 2006). Furthermore, an uni-
form terminology was agreed on to avoid further confusion. During the nearly 40 years
after the first report of MSCs, several terms can be found in the literature: Introduced
as osteogenic stem cells (Friedenstein et al., 1970), Caplan coined the popular term of
mesenchymal stem cells (Caplan, 1991) while now MSCs should be addressed as mul-
tipotent ’mesenchymal stromal cells’, and this term and definition is used throughout
this thesis.
Since the 1990s MSCs have been used in various therapeutic approaches of tissue en-
gineering and clinical regenerative medicine due to their potential to differentiate into
diverse cell types like osteoblasts, adipocytes, or chondrocytes (Prockop, 1997; Pittenger
et al., 1999; Gregory et al., 2005): Infusion of MSCs improved the outcome in children
with osteogenesis imperfecta (Horwitz et al., 2002). Direct injection of concentrated
bone marrow for the treatment of long-bone fractures supported bone healing when
applying MSCs from bone marrow (Hernigou et al., 2005) and also MSCs in combi-
nation with tissue engineering was succesfully applied for bone replacement (Quarto
et al., 2001). MSCs transplanted into infarcted heart and stimulated to differentiate
into cardiomyocytes by 5-azacytidine reduced the size of damaged tissue (Tomita et al.,
1999) and MSCs can also differentiated in vitro into functional beating cardiomyocytes
(Makino et al., 1999; Planat-Benard et al., 2004a). Furthermore, MSC mediated en-
hancement of epithelial wound healing was shown. However, it needs to be clarified,
whether MSCs contribute to wound healing by transdifferentation, for example into
cornea cells (Arnalich-Montiel et al., 2008). Alternatively paracrine effects could stim-
ulate neighboring stromal cells (Oh et al., 2008), by either recruiting macrophages or
endothelial lineage cells (Chen et al., 2008) or, most likely through multiple combined
pathways. MSCs can not only be implanted in diverse anatomical sites for tissue re-
pair using their differentiation potential to resume physiological processes, reports have
shown prevention of graft versus-host-disease (GvHD) and enhanced engraftment in
haematopoietic stem cell transplantation in combination with MSCs (Le Blanc et al.,
2008; Muller et al., 2008; Kim et al., 2004). Moreover, in response to cytokines and other
soluble factors, they can also migrate into inflammatory sites and tumor surrounding
2
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stroma (Mishra et al., 2009). Thus, genetically manipulated MSCs could deliver drugs
to the tumor microenvironment for interference with tumor growth (Hall et al., 2007;
Bexell et al., 2009).
However, besides envisaged therapeutic benefits, MSCs also carry potential risks.
Spontaneous differentiation into osteogenic lineage including increased calcification by
MSCs injected into rat hearts, demonstrated pitfalls in therapeutic application of MSCs
(Breitbach et al., 2007). Not only development of ’wrong’ tissues can occur, there
are also reports that MSCs resident in tumor stroma converted into cells resembling
carcinoma associated fibroblasts (CAFs) (Galiè et al., 2008; Mishra et al., 2009), though
distinct markers to trace their fate or function are still elusive. Among other factors,
CAFs secrete stromal derived factor-1 (SDF-1) that stimulates tumor cell proliferation
and migration via SDF-1 receptor (CXCR4) (Orimo et al., 2005). Moreover, SDF-1
recruits endothelial precursors from bone marrow, favoring tumor angiogenesis. Other
biomarkers suggest a strong relationship of MSCs with perivascular cells or pericytes
which are essential for functional maturation of blood vessels (Brachvogel et al., 2005;
Bexell et al., 2009; Paquet-Fifield et al., 2009; Bianco et al., 2010). Underlining MSC
plasticity, mesenchymal-epithelial transitions have been reported, possibly generating
also malignant epithelial cells, but this is still a controversial issue and in several cases
cross-contamination in culture has been uncovered (Orimo et al., 2005; Rubio et al.,
2008; Garcia et al., 2010). For all applications a challenging problem remains that cell
isolates represent mixed populations, containing early precursors with a wide poten-
tial, cells committed already to distinct lineages or more specialized fibroblastoid cells
(Bianco et al., 2010).
1.1.1 Differentiation of MSCs
The ability of MSCs to differentiate into cells of various tissue types as major hallmark
of their properties is the most obvious benefit for clinical application. Besides fulfilling
the minimal criteria for MSCs to give rise to adipogenic, osteogenic and chondrogenic
cells (Gregory et al., 2005), differentiation into myocytes (Zuk et al., 2001), hepatocytes
(Banas et al., 2007; Seo et al., 2005), neurons (Safford et al., 2004), pancreatic cells
(Timper et al., 2006) and also into endothelial cells (Planat-Benard et al., 2004b) was
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shown in various studies. In this thesis the main focus is on adipogenic and osteogenic
differentiation.
1.1.1.1 Adipogenic differentiation
Differentiation along the adipogenic pathway is not only one of the crucial characteristics
of MSCs, but might also be of clinical relevance for example in fat grafting for the treat-
ment of contour deformities (Yoshimura et al., 2008). Early adipogenic differentiation
is marked by increased levels of CCAAT/enhancer binding protein β (C/EBPβ) and
CCAAT/enhancer binding protein δ (C/EBPδ) which in turn activate as heterodimers
peroxisome proliferative activated receptor γ (PPARγ), one of the major proteins in
adipocyte maturation and maintenance. PPARγ is thought to play a role in the growth
arrest at G0/G1 phase typically seen for cells at the onset of adipogenic differentiation.
This is followed by cell doubling for clonal amplification of committed cells (Pairault and
Green, 1979). PPARγ activates C/EBPα, both leading to activation of adipogenic spe-
cific genes like adiponectin, perilipin, leptin, fatty acid synthase and fatty acid binding
protein. But C/EBPα also serves as negative effector by decreasing the early adipogenic
markers C/EBPβ and δ. By accelerating the degradation of β-catenin, PPARγ partic-
ipates in suppression of Wnt-signaling, thus inhibiting osteogenesis (Liu and Farmer,
2004).
Morphologically adipogenic differentiation is accompanied by drastic changes of the
cell shapes from an elongated fibroblast-like morphology into more roundish cells con-
taining large accumulations of lipid droplets. The conversation into mature adipocytes
is preceded by a decreased assembly of the cytoskeletal proteins actin and tubulin (Gre-
goire et al., 1998; Spiegelman and Ginty, 1983). For adipogenic differentiation in vitro,
usually MSCs at confluent stage are stimulated with a cocktail of factors which trigger
or accelerate adipogenesis such as dexamethasone, insulin, 3-isobutyl-l-methyl-xanthine
(IBMX), and indomethacine. The glucocorticosteroide dexamethasone increases expres-
sion of the early adipogenic markers C/EBPδ and decreases glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) mRNA. The phospohodiesterase inhibitor IBMX increases the
level of 3’-5’ cyclic adenosine monophosphate (cAMP) which in turn activates protein
kinase A (PKA). Perhaps of more input IBMX directly acts on the adipogenic dif-
ferentiation process by increasing C/EBPβ levels. Indomethacine accelerates adipo-
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genesis by increasing C/EBPβ expression in a prostaglandin-independent manner and
by inhibiting of cAMP degradation but it might also be a direct agonist for PPARγ.
In addition indomethacine increases levels of ADRP (Adipocyte differentiation-related
protein, also termed adipophilin) which leads to accumulation of triglycerides and fat
storage. Finally, due to its inhibitory activity on cyclooxygenases indomethacine also
acts as negative effector of osteogenesis (Styner et al., 2010; Lehmann et al., 1997; Gre-
gory et al., 2005). Insulin and also insulin-like growth factor (IGF)-1 are not only major
regulators of glucose uptake, thus fueling lipid metabolism, but might also play a role
in stimulation of the clonal amplification of committed adipogenic cells.
1.1.1.2 Osteogenic Differentiation
Their potential to differentiate into osteoblasts and the resulting ability to form bone
matrix qualifies MSCs for therapeutical application supporting bone repair after in-
juries. At the cellular level the ossification process can be divided into three major
stages of differentiation: (i) proliferation of precursor cells and mature osteoblasts, (ii)
production and maturation of extracellular matrix (ECM), and (iii) cell-mediated min-
eralization of the matrix (Aubin, 2001). Each stage is accompanied by expression of
a specific set of genes. Central player in osteogenesis is runt-related transcription fa-
tor 2 (Runx2), also termed Cbfa-1, which is activated via bone morphogenic proteins
(BMPs) or ERK 1 and 2 dependent pathways (Lee et al., 2000; Salasznyk et al., 2004).
Underlining its importance knock out of Runx2 leads to accumulation of immature os-
teoblasts and preventing of bone formation in mice (Komori et al., 1997; Otto et al.,
1997). Activated Runx2 binds to osteoblast-specific cis-acting element 2 (OSE2) and
induces several osteogenesis related proteins (Ducy et al., 1997; Hoshiba et al., 2009).
One of those, osteopontin (OPN) shows two peaks of high gene expression, the first
between day 4 and 6 after induction of differentiation and the second at late phase
when matrix and mineralization are almost fully developed. Similarly, increased levels
of bone sialoprotein (BSP) are also detectable in a very early and at late phase. In
contrast, alkaline phosphatase (ALP) is expressed exclusively during early stages, ini-
tiating mineralization of the ECM by hydrolyzation of organic phosphates (Stanford
et al., 1995). The ALP level decreases when mineralization is fully developed (Aubin,
2001). At this late stage again Runx2 induced genes are highly expressed as BSP and
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other osteogenic specific markers like osteocalcin (OCN). Complete osteogenic differen-
tiation in vitro is marked by deposits of calciumphosphate and hydroxyapatite in the
mineralized matrix of cultured cell layers. Although cultivation of MSCs in medium
containing dexamethasone, ascorbic acid and β-glycerophosphate (BGP) was shown to
be efficient for in vitro osteogenic differentiation (Pereira et al., 1995; Colter et al.,
2000), these conditions might not reflect the in vivo signals. Contradictory results for
the role of bone morphogenic protein (BMP)2 in osteogenesis have been reported (Gre-
gory et al., 2005; Hanada et al., 1997; Diefenderfer et al., 2003) whereas osteogenic
differentiation has been also induced by other factors like 1α,25-dihydroxyvitamineD3
or 9-cis retinoic acid (Jørgensen et al., 2004; Titorencu et al., 2007). During the process
of induced in vitro differentiation ascorbic acid increases the production of collagen and
ALP activitiy in cells undergoing osteogenic differentiation (Maniatopoulos et al., 1988;
Chan et al., 1990). The secreted collagens (mainly type I collagen) bind to integrin
α1β1 at the cell surface, activating intracellularly ERK proteins which in turn initiate
a signaling cascade which ends in activation of Runx2 (Salasznyk et al., 2004). For
matrix mineralization BGP serves as organic phosphate source for the osteogenic cells.
Though dexamethasone is not essential for osteogenic differentiation, it apparently in-
creases the osteogenic output of cells which differentiate. However, for its stimulating
effect on adipogenic differentiation and the known negative influence of glucocorticoides
on bones, the role of dexamethasone might be of ambivalent nature (Aubin, 2001).
1.2 The extracellular matrix and the stem cell niche
A central role for the pool of stem cells and their fate plays the stem cell niche, the
environment in which genuine stem cells are located including surrounding cells, the
composition of the surrounding ECM as well as growth factors bound or produced
there. The stem cell niche not only maintains the self-renewal properties and regulates
proliferation but also prevents or, upon appropriate stiumuli, directs stem cell differen-
tiation (Warstat et al., 2010). Stem cells which are triggered to migrate out of their
niche by extrinsic factors like cytokines or growth factors may enter circulation or can
start to proliferate and differentiate into different lineages after homing at specific sites.
For therapeutic application the maintenance of stemness of the cells in vitro is of cru-
cial importance. Thus, major issues are, (1) providing an environment which allows
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proliferation of the stem cells without losing their potential to differentiate and (2) the
developing of factor-conditioned supports or matrices which are favorable for certain
lineages. This will be of highest interest for either tissue engineering or direct clinical
application of MSCs. Due to its protein composition the extracellular matrix (ECM)
provides a scaffold for tissues and the cells within it. The composition of ECM macro-
molecules varies from tissue to tissue and through specific cell-matrix contacts the ECM
plays also a regulatory role in cell adhesion, proliferation, migration, differentiation and
cell behavior in general. In the context herein, these interactions with the ECM are
essential for stem cells mediating their homing in the stem cell niche (Warstat et al.,
2010). Concordantly, cultivation of MSCs on certain ECM proteins can improve the
maintenance of differentiation potential in vitro (Volloch and Kaplan, 2002) but also
promote (Salasznyk et al., 2004; Mizuno and Kuboki, 2001) or inhibit certain differenti-
ation pathways (Mauney and Volloch, 2009, 2010; Santiago et al., 2009) which is further
refined by structural and mechanical substrate properties like stiffness or elasticity (En-
gler et al., 2006; Rowlands et al., 2008). These signals from the outside (ECM) into the
cell are mainly mediated by integrins (outside-in signaling) which triggers the cellular
responses such as growth or maintenance of stemness, migration and differentiation.
1.2.1 Proteins of extracellular matrix
The ECM is made up by a large number of proteins and its composition varies from tissue
to tissue, determining ECM function. ECM proteins can be grouped into collagens and
other glycoproteins, both capable of self-assembly, and less structured proteoglycans.
Due to their extended use this section further describes ECM proteins collagen I and
IV as well as laminin and fibronectin.
1.2.1.1 Collagens
Collagens are the most abundant proteins in vertebrates, being present amply in all
connective tissues and in varying amounts in virtually all organs. Collagen terms for
a group of several subfamilies of trimeric proteins sharing structural and functional
properties. All collagens express domains with triple helical conformation giving rise
to rigid, rod-like molecular structures. Collagens such as fibrillar (type I, II, III, V
and VI collagen) or short chain collagens (type VIII and X collagen) express only one
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triple-helical domain spanning almost the entire length of the molecule. Other colla-
gens such as basement membrane (BM) collagens (type IV collagens, several isoforms),
FACITs (fibril-associated collagens with interrupted triple helices: type IX, XII, XIV,
XVI and XIX collagen) or MACITs (membrane-associated collagens with interrupted
triple helices: type XIII and XVII) are composed of show short triple helical domains
which are interrupted by non-helical sequences (Kühn, 1995). The subunits of these su-
perhelices, called α-chains contain the repetitive sequence motif (Gly-X-Y)n, frequently
with proline in the X or Y position besides any other amino acids. This is an absolute
prerequisite for the typical rod-like collagen structure being stabilized through regu-
larly spaced hydrogen-bonds. In addition collagens are stabilized by a high content of
hydroxyproline through specific hydroxylation of proline in Y-position. This is raising
the number of hydrogen-bonds and thus the degree of hydroxylation is further increas-
ing the thermal denaturation temperature. Usually, collagens form fibrils, filaments
or networks. The formation of these supramolecular aggregates occurs either by pure
self-assembly or together with other extracellular components such as decorin or the
’minor’ collagen types (FACITs). Collagens mostly contribute to the stable scaffold of
ECM-structures, but also to the anchorage of cells to the ECM. Direct adhesion of cells
to collagen occurs in a conformation dependent manner, mostly recognizing distinct
triple-helical binding sites by integrins, in particular integrin α1β1 and α2β1. In addi-
tion, collagens can exhibit regulatory functions as well (Kreis and Vale, 1999). Thus,
different types of collagens have an influence on cell differentiation and migration during
development, in most cases also mediated via integrins.
Collagen type I is the predominant collagen in striated collagen fibrils. Its fibril-
lar structure makes collagen I the major protein in various tissues. It forms rope-like
structures in tendon, sheet-like structures in skin, and in bone collagen I makes up
to 90% of the total protein matrix which is aligned and reinforced by calcium hy-
droxyapatite. Thus, it provides the essential scaffold for ordered mineralization and
provides bone a certain degree of elasticity. The molecular structure of collagen I is
dominated by a long uninterrupted triple helical domain built by heterotrimers of two
α1(I) and one α2(I) chain, also an α1(I)3 isoform exists but at low abundancy. Intra-
cellularly synthesized heterotrimeric procollagens are secreted and propeptide regions
are removed by N- and C-proteinases in the extracellulare space. These mature triple-
helical molecules assemble into cross-banded fibrils, stabilized by further cross-linking
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of specific lysine/hydroxylysine residues and non-helical as well as helical domains. Di-
rect interactions of collagen I and cells is mainly mediated via integrin α1β1 and α2β1
(Staatz et al., 1991; Mecham, 2011).
Collagen Type IV, a major component of basement membranes, is a network-
forming collagen and consists of variable combinations of six different α chains. The
major part of type IV collagen is made up by a hetero-trimeric isoform consisting of
two α1(IV) and one α2(IV) chain. Two further combinations of α-chains are found,
which are from minor incidence: α3(IV)α4(IV)α5(IV) and α5(IV)α6(IV). Structurally
the α-chains can be separated into 3 domains: the N-terminal cysteine rich (7S) do-
main, a central triple helical domain and a non-triple helical domain (NC-1) at the
C-terminal end of the molecule (Khoshnoodi et al., 2008). Network assembly of col-
lagen IV is initiated by covalent cross-linking through its 7S domains, forming dimers
and in a further step tetramers. Aggregation of tetramers is accomplished through
end-to-end interactions of the C-terminal NC1-domains, finally forming a chicken-wire
like network. Additionally, the network is stabilized by lateral associations between
triple helical domains (Timpl et al., 1981). While the α1(IV)2α2(IV)-form is highly
abundant, the α3(IV) to α6(IV)-chains are found only in specialized BMs. Thus, the
α3(IV)α4(IV)α5(IV) network is expressed in lung, kidney and neuromuscular junctions
and the α5(IV)α6(IV) chains are restricted to BMs lining epidermal and smooth muscles
cells, adipocytes, and kidney tubules (Kühn, 1995; Miner, 2011). In BMs the networks of
collagen IV are closely linked, which is largely mediated by nidogen, further stabilizing
BM structure (Breitkreutz et al., 2004; Nischt et al., 2007).
1.2.1.2 Laminin
Up to now, of the large glycoyprotein family of laminins at least 15 members are known.
Each isoform consists of an α-, β- and γ-polypeptide chain, forming a heterotrimeric
glycoprotein. Five different α-chains, four β-chains and three γ chains have been iden-
tified, which give the laminins a large variety of functional and biological activities.
Nomenclature of laminins was revised in 2005 changing names from numeral ordered
laminins according to their discovery to a 3-digit system based on their chain compo-
sition (Aumailley et al., 2005). So, laminins-5, -6 and -10, being most abundant in the
basement membrane zone of adult skin (McMillan et al., 2003; Miner and Yurchenco,
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2004), have been renamed laminin-332 (Lm-322), Lm-311, and Lm-511 for examples.
Apparently β- and γ- chains are assembled first in the cell, while the addition of the
α-chain is required for secretion. Genuine, i.e. unprocessed laminins have a cross- or
T-shaped structure. The rod-like arm consists of the coiled-coil domains of the three
different chains, held together by hydrophobic and polar interactions, and five globu-
lar laminin G-like domain (LG)-modules (LG1-LG5) at the C-terminus of the α-chain.
The two or three short arms, are contributed by either the β and γ or all three chains,
containing repeats of laminin type EGF (epidermal growth factor)-like domain (LE)-
modules, interrupted by one or two globular L4 modules which are all individually sta-
bilized by interchain disulphide bonds (Kreis and Vale, 1999; Ghohestani et al., 2001;
Aumailley and Rousselle, 1999). The first step of polymeric self-assembly and network
formation is mediated by interactions of the N-terminal ’sticky’ ends (LN domains) of
the short arms. In the BM zone, connection to the collagen IV networks occurs through
nidogen binding at the γ1III4-module of laminin though nidogen-binding presumably
also adapts laminin conformation for interactions (Breitkreutz et al., 2004). Laminins
not only contribute to the formation of networks but are also directly involved in cell
adhesion via integrins, especially the integrins α3β1, α6β1, α6β4 and α7β1 (Miner,
2011). The function of the individual laminins is considerably modified by proteolytic
processing, especially clipping off LG4 and LG5 or N-terminal parts of the α and γ short
arms. This processing is particularly extensive on Lm-332. While Lm-111 is prominent
(mostly in the BM) during embryonic development, the most abundant laminin in hu-
man adults is Lm-511. Whereas the α1 and α5 chain apparently cannot compensate for
each other despite of high sequence homology, the β1 and γ1 chains are essential in BM
formation. Defects in the expression of α5-chain are related to various developmental
defects which are generally embryonic lethal (Miner and Yurchenco, 2004; Rebustini
et al., 2007). Though the underlying mechanisms are not fully understood, this clearly
points out that a functional basement membrane is essential for proper tissue function
and signaling to adjacent cells.
1.2.1.3 Fibronectin
Another major protein of the extracellular matrix is the ubiquitous glycoprotein fi-
bronectin (Fn). Two large subunits connected through disulfide bonds on the C-terminal
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end form the basic dimeric structure of fibronectin. Each subunit can be divided into
several domains which in turn contain different functional modules, responsible for
crosslinking of fibronectin molecules, binding of cells or other ECM molecules like col-
lagens, fibrin and heparin. Various isoforms of fibronectin-subunits are found which
is caused by alternative splicing giving rise to 20 different fibronectin mRNAs. Cell
binding of fibronectin occurs mainly through an RGD motif in the ’type III fibronectin
(FnIII) repeat’ in the cell binding module which is interacting with various integrins,
primarily α5β1 integrins, on the cell surface (Mao and Schwarzbauer, 2005). Bind-
ing of a LDV sequence motife with integrins α4β1 or α4β7 to a LDV sequence motif
could be also detected in the alternatively spliced FnV region (Humphries et al., 2006;
Leiss et al., 2008). In contrast to the self-assembling networks of collagens or laminins,
these interactions of fibronectin with cells are a prerequisite for fibril formation in the
extracellular matrix of tissues. As long as not bound to cells the cryptic binding site
for fibronectin self-assembly is hidden in the molecular structure. Getting bound to
cells the fibronectin molecules are stretched by cell mediated tension via integrins and
intracellular actin stress fibers, which is exposing the binding module. The fibronectin
molecules can now interact with other to form fibrilar networks around cells, thus con-
necting neighboring cells and contributing to matrix (ECM) organization (McDonald,
1988; Singh et al., 2010). This function is essential for keeping fibronectin monomeric
and soluble e.g. to prevent formation of clumps in the bloodstream by spontaneous
self-assembly (Alberts et al., 2007; Xu et al., 2009). Defects in fibronectin expression
have severe effects particularly on the interactions of vascular cells with the ECM. Mice
not expressing fibronectin are unable to form mature blood vessels and die at an early
embryonic stage (George et al., 1993). Furthermore, fibronectin participates in wound
healing, where conditional knockout of fibronectin was shown to provoke impairment of
thrombus formation, growth and stability after injuries (Ni et al., 2003).
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1.3 Impedance measurements
The principle of impedance measurement to monitor cell behavior electrically in tissue
culture was first reported by the pioneering work of Giaever and Keese (1984) and was
further developed into an own field of biosensors using this method called electric cell-
substrate impedance sensing (ECIS) (Giaever and Keese, 1993). Based on this principle
today several systems, each equipped with its own specific features like additional sen-
sors for pH, temperature, glucose or oxygen-consumption evolved (Kirstein et al., 2006;
Thedinga et al., 2007; Wiest et al., 2006). To monitor cell behavior electrically cells
are grown in tissue culture vessels in which bottom (gold) electrodes are incorporated.
Cel-free electrode
Cels atach on electrode reducing curent and thus increasing 
impedance
Current flow
Cels spread on electrode further increasing impedance
Figure 1.1: Principle of impedance
measurement
An alternating current (AC) signal of
several kHz is applied on the electrodes
and the resulting voltage can be mea-
sured to calculate the impedance, the AC
equivalent to electric resistance. There-
fore its unit is also Ohms (Ω). When cells
are seeded in these culture wells and start
to attach on the electrodes they serve
mainly as insulators and restrict the cur-
rent flow, thus increasing the impedance
(Fig. 1.1). In general, impedance is
closely related with the covered area of
the electrodes, thus mainly influenced by
the cell number and size of the cells at-
tached to the electrodes, but also cell-cell
and cell-substrate/ECM interactions fur-
ther contribute to the overall impedance values. Therefore, the impedance profiles,
varying in magnitude and initial slopes depending on cell morphology and attachment
of the cells, reflect cell type and cell state and this method may be used as a valuable
tool to characterize cells in a continuous but non-invasive manner (Giaever and Keese,
1993). Further interpretation of impedance data can be obtained if the phase of voltage
12
1.3 Impedance measurements
is also considered. Measuring voltage and the phase of the voltage, impedance can be
broken down into a pure resistive part R
R = V (inphase)I
and a capacitive portion Xc
Xc =
V (outphase)
I
with
I electric current
and finally the impedance Z is given as
Z =
√
R2 +X2c
herein Xc depends on the applied frequency of the AC, this parameter allows calculation
of the capacitive proportion C of the impedance
Xc =
1
2pifC
with
f frequency of the applied alternating current.
Based on this, a mathematical model was developed which determines three parameters
further describing impedance data (for details see Giaever and Keese (1991) and Lo et al.
(1995)). Therein, the current flows beneath the cells are defined by the cell-substrate
parameter α which mainly depends on the cell size and the space between the cells
and the substratum. The spaces and formed junctions between the cells determines the
current flowing through the cell layer and defines the barrier resistance Rb. Finally, due
to the plasma membrane the membrane capacitance Cm can be considered as well.
However, in this thesis two different impedance based systems were used both only
measuring the parameter of impedance Z without regard to other parameters. The
ECIS system (Applied Biophysics) allows microscopic evaluation of the cells but only a
small fraction of the bottom of the well is covered with measuring electrodes, whereas
the xCELLigence system (Roche) covers approximately 80% of the growth area but
microscopy is hardly restricted due to the close gold layers. Further description of the
systems can be found in 3.4.
13
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In the last decade multipotent mesenchymal stromal cells (MSCs) developed more and
more to attractive candidates for therapeutical applications and tissue engineering. This
is closely related to their mesodermal differentiation potential but also to further charac-
teristics like immunomodulary properties. Differentiation of cells is often accompanied
by changes in cell morphology, adhesion and changes of interactions with their environ-
ment including extracellular matrix- and cell-to-cell contacts.
This present thesis evaluates how cell adhesion is influenced during differentiation
processes by interactions with proteins of the extracellular matrix or vice versa how
these cell-matrix interactions further contribute to direction of cell differentiation. The
process of differentiation of MSCs is monitored in a non invasive manner using real time
impedance measurements in live cell chips. Impedance mainly reflects cell layer resis-
tance against alternating current and, to a minute extent, cell surface electric capacity.
For the present work the question was raised if impedance-based assays can determine
changes in cell morphology and interactions during differentiation processes of MSCs
and how this correlates to differentiation of the cells, determined by traditional histo-
chemical staining, gene, and protein expression profiling. Furthermore, mobilization or
migration from their stem cell niche and the guidance of migration into sides of injured
tissue is mainly triggered by secretion of certain factors from inflammatory tissue. The
migratory properties of MSCs during differentiation and in response to certain extrinsic
factors were studied.
Overall this thesis aims on further characterization of MSC differentiation and, fur-
thermore, cell-matrix interplay during differentiation and evaluates the readiness of
impedance tools for studying cell differentiation mainly via changes in cell morphology
and adhesive properties.
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3 Materials and Methods
The present thesis was accomplished in a molecular-biological laboratory, classified
biosafety level S1, considering all safety precautions. All used chemicals were of an-
alytical grade or met the requirements for cell culture.
3.1 Materials
3.1.1 General materials
Name Information / Supplier
Camera Digital true color camera, ColorView212; SIS
Camera Digital b/w camera F-View; SIS
Camera Digital camera Camedia C-2020; Olympus
Devoloper Agfa
Electrophoresis chamber MiniVE System; Hoefer
Electrophoresis chamber Model H5; Bethesda Research
Film processor Classic E.O.S Typ 5270; Agfa
Fixer Agfa
Fluorescence - and Lightmicroscope AX-70; Olympus
Fluorescence - and Lightmicroscope DM RD; Leica Microsystems
Spectrophotometer Fluoroskan; Ascent Labsystems
Incubator CO2-Incubator CB210; Binder
Light Cycler 480 Roche
Lightmicroscope BX-51; Olympus
Lightmicroscope IX-70; Olympus
NanoDrop NanoDrop 3300; Thermo Scientific
pH Meter PB-11; Sartorius
Power supply PowerPac Basic; BioRad
Power supply GPS200/400; Pharmacia
Thermal Cycler PTC-200; BioRad
Transfer system BioRad
UV illuminator MultiImage Light Cabinet; Fisherbrand
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3.1.2 Materials for the cell culture
Name Information / Supplier
µ-Slide µ-Slide 8 well coated; ibidi
8W10E+ ibidi / Applied Biophysics
8W1E ibidi / Applied Biophysics
Cell counter Casy® Modell TTC; Schärfe Systme GmbH
Cell culture flasks T25-, T75, T175 cell culture flasks; Greiner BioOne
Cell culture dishes 15 cm-, 10 cm- 6 cm-, 3.5 cm- tissue culture treated
dishes; BD Bioscience
Coverslips 24x60mm; Menzel Gläser
Coverslips round, 13 mm diameter; Neolab, Karl Hecht GmbH
ECIS instrument ECIS Model 1600; ibidi / Applied Biopyhsics
E-plate 16 Roche
Freezing container Mr. Frosty Freezing Container; Nunc
Freezing vials Cryotube; Nunc
Microscope slide 76x26mm; R.Langenbrinck
MSA-Slide Multiple Substrate Array; Biocat
Multi-well plates 6-well, 24-well, 96-well plate; BD Biosciences
Polypropylen-falcon 15 mL vials; BD Biosciences
Polypropylen-falcon 50 mL vials; BD Biosciences
Cell lifter Costar
Silicon inserts ibidi
xCELLigence instrument Real time cell analyzer (RTCA); Roche
3.1.3 Chemicals and solutions for the cell culture
Chemical Information / Supplier
Acetic Acid Sigma-Aldrich
AIM Adipogenic Induction Medium containing dexametha-
sone, h-insulin (recombinant), indomethacine, IBMX,
L-glutamine, Growth Supplements, Gentamicin, Am-
photericin B; Lonza
AMM Adipogenic Maintenance Medium containing h-Insulin
(recombinant), L-glutamine, Growth Supplements,
Gentamicin, Amphotericin B; Lonza
Blasticidin S Invitrogen
CASYton Schärfe System GmbH
Collagen type I from rat tail tendon; Roche
Collagen type IV from human placenta; Sigma-Aldrich
Collagenase Type I Sigma-Aldrich
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DMEM Dulbecco’s Modified Eagle’s Medium, 4.5g/l glucose,
with L-glutamine; Lonza
DMSO Dimethyl sulfoxide; Sigma-Aldrich
Doxycycline Sigma-Aldrich
EDTA 0.05% in PBS + 1µl/ml phenol red; Serva
FCS fetal calf serum; Gibco
Fibronectin from human plasma; Roche
Ficoll-Hypaque-Plus GE Healthcare BioScience;
Glycerol Roth
Laminin from Engelbreth-Holm-Swarm sacroma (mouse);
Roche
MSC-GM Mesenchymal Stem Cell Growth Medium containing
L-glutamine, Gentamicin, Amphotericin B; Lonza
OIM Osteogenic Induction Medium, containing dexametha-
sone, β-glycerophosphate, ascorbate, L-glutamine,
Growth Supplements, Penicillin/Streptomycin; Lonza
PBS Serva
PDGF recombinant human PDGF-AB; Peprotech
Penicillin/Streptomycin 10000 U/10000 µg/ml; Biochrom
SDF-1α recombinant human SDF-1α; Peprotech
TNFα recombinant human TNFα; Peprotech
Triton X-100 Gerbu
Trypsin 0.1% in 0.05% EDTA/PBS; Roche
Zeocin Invitrogen
3.1.4 Chemicals and solutions for staining
Chemicals Information / Supplier
Alizarin Red S Solution 40 mM Alizarin Red S (Sigma-Aldrich) in H2O, pH 4.1
adjusted with 10% ammonium hydroxide
Antibody solution 2% BSA in PBS
Blocking solution 5% BSA, 0.02% Tween20 in PBS
BSA Bovine serum albumine; PAA
Formaldehyde 3.7% Paraformaldehyde; Merck in PBS
Hoechst33258 Serva
Isopropanol Sigma-Aldrich
Mounting medium Dako
Oil Red O Stock Solution I 3% Oil Red O (w/v) (Sigma) in isopropanol
Oil Red O Stock Solution II 0.5% Oil Red O (w/v) (Sigma) in 60% Triethyl phos-
phate (v/v) (Fluka)
Phalloidin FITC-labeled phalloidin; Sigma-Aldrich
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Pyrogallol solution Sigma-Aldrich
Silver nitrate Sigma-Aldrich
Sodium thiosulfate Merck
Triton X-100 0.5%, Gerbu
Tween20 MP Bio
Whatman paper 42 Whatman
3.1.5 Primary antibodies for immunofluorescence staining
antigen produced in dilution Cat-# Supplier
Nidogen-1 rabbit 1:500 n/a gift from R. Nischt, Cologne
Vimentin guinea pig 1:100 GP53 Progen
Cytokeratin guinea pig 1:100 GP14 Progen
3.1.6 Secondary antibodies for immunofluorescence staining
produced in dilution Cat-# Supplier
anti-guinea pig Cy3 donkey 1:800 706-165-148 Dianova
anti-rabbit Cy3 donkey 1:1000 111-165-144 Dianova
3.1.7 Chemicals and solutions for protein analysis
Information / Supplier
Acrylamide 40% Acrylamide/Bis solution 37.5:1 (2.6%C); BioRad
Aprotinin Sigma-Aldrich
APS ammonium persulfate; Serva
β-mercaptoethanol Merck
Blocking buffer 5% skim milk powder in TBS-T
Blot membrane Nitrocellulose membrane; Whatman
Bradford reagent Protein Assay; Biorad
Bromphenol blue Serva
BSA Bovine serum albumine; PAA
Collection gel 0.95 ml collection gel buffer, 2.6 ml H2O, 0.3 ml acry-
lamide, 22.5 µl 10% APS, 7.5 µl TEMED
Collection gel buffer 0.5 M Tris-HCl pH 8.8, 0.4% SDS
ECL Enhanced Chemiluminescense, GE Healthcare
EDTA Serva
Glycerol Roth
Glycine Gerbu
Leupeptin Biomol
Loading buffer 20% glycerol, 10% β-mercaptoethanol, 25% collection
gel buffer, 6% SDS, bromphenol blue in dH2O
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Lysis buffer 10 mM Tris pH 7.2, 150 mM NaCl, 1% Triton X-100,
0.1% sodium desoxycholate, 0.1% SDS, 5 mM EDTA,
containing 100 nM sodium orthovanadate, 10 nM Pefa-
bloc, 1 µg/µl Leupeptin, 1 µg/µl Pepstatin, 1 µg/µl
Aprotinin
Methanol Sigma-Aldrich
Pefa bloc Biomol
Pepstatin Biomol
Ponceau S 5x Concentrate solution; Fluka
Protein Marker PeqGold Protein Marker V, PeqLab
Running buffer 30 mM Tris, pH 8.3, 500 mM glycine, 0.1%SDS
Separation gel, 10% 2.5 ml separation gel buffer, 0.75 ml 50% glycerol, 4.25
ml H2O, 2.5 ml acrylamide, 100 µl 10% APS, 10 µL
TEMED
Separation gel, 6% 2.5 ml separation gel buffer, 0.75 ml 50% glycerol, 5.25
ml H2O, 1.5 ml acrylamide, 100 µl 10% APS, 10 µl
TEMED
Separation gel buffer 1.5 M Tris-HCl, pH 6.8, 0.4% SDS
Skim milk powder Roth
Sodium chloride Sigma-Aldrich
Sodium desoxycholate Merck
Sodium dodecyl sulfate
(SDS)
Gerbu
Sodium ortho vanadate Sigma-Aldrich
Strip buffer 62.5 mM Tris, pH 6.7, 2% SDS, 1% β-mercaptoethanol
TBS 150 mM NaCl, 20 mM Tris
TBS-T TBS, 0.1% Tween 20
TEMED N,N,N’,N’-Tetramethylethylenediamine; Sigma-
Aldrich
Transfer buffer 30 mM Tris, 500 mM glycine, 20% methanol
Tris Sigma-Aldrich
Tris-HCl Sigma-Aldrich
Triton X-100 Gerbu
Tween 20 MP Biomedicals
X-Ray films Super RX Fuji medical x-ray film; Fujifilm
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3.1.8 Primary antibodies for protein detection
antigen produced in dilution Cat-# Supplier
ACT rabbit 1:1000 sc-1616 Santa Cruz
ADRP mouse 1:1000 AP125 Progen
BSP mouse 1:1000 ab58825 Abcam
OPN rabbit 1:1000 ab8448 Abcam
PER guinea pig 1:2000 GP29 Progen
TUB mouse 1:200 T4026 Sigma-Aldrich
3.1.9 Secondary antibodies for protein detection
produced in dilution Cat-# Supplier
anti-guinea pig POX rabbit 1:10000 A-5545 Sigma-Aldrich
anti-mouse POX donkey 1:10000 715-035-150 Dianova
anti-rabbit POX donkey 1:10000 711-035-152 Dianova
3.1.10 Chemicals for PCR
Chemicals Information /Supplier
Agarose Biozym
cDNA synthesis Transcriptor High Fidelity cDNA Synthesis Kit; Roche
CoralLoad PCR buffer Qiagen
DNA ladder 100 bp Plus DNA ladder, Fermentas
dNTPs Sigma-Aldrich
Omniscript RT Kit Qiagen
Primer Thermo Scientific
Probes Human Universal Probe Library; Roche
QIAshredder Qiagen
RNase Inhibitor Protector RNase Inhibitor; Roche
RNeasy Mini Kit Qiagen
RT-qPCR reaction Light Cycler 480 Probes Master; Roche
SYBRSafe Invitrogen
TAE 40 mM Tris base, 20 mM acetic acid and 1 mM EDTA
buffer
Taq DNA-Polymerase Qiagen
96-well plates for RT-qPCR, FrameStar; Axon
96-well cover foil Axon
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3.2 Cells and cell lines
3.2.1 Mesenchymal stromal cells
Mesenchymal stromal cells (MSCs) were generously provided by Karen Bieback’s labora-
tory at University Hospital Mannheim. Cells were isolated from bone marrow (BMSCs,
3 donors) or adipose tissue (ASCs, 2 donors) as described previously, complying eth-
ical standards (Kern et al., 2006). In brief, bone marrow aspirates were diluted with
2 mM EDTA-PBS and mononuclear cell fractions were isolated by centrifugation on
Ficoll-Hypaque-Plus density gradients. Lipoaspirates were digested with 0.075% col-
lagenase type I for 30-45 minutes at 37℃, blocking activity with basal medium, and
stromal fractions were peletted, resuspended and filtered through gauze. Both BMSCs
and ASCs suspended in complete mesenchymal stem cell growth medium (MSC-GM)
were seeded at a density of 1 x 106 cells/cm2 into T75 or T175 culture flasks. Non-
adherent cells were removed with first medium change within 3 days after plating and
the resulting fibroblastoid cells expanded in MSC-GM. All MSC isolates used herein
fulfilled the minimal criteria defined by the ISCT (Dominici et al., 2006; Kern et al.,
2006; Bieback et al., 2010).
3.2.2 Fibroblasts
Human fibroblasts were isolated from the dermis of healthy human skin obtained from
the Department of Dermatology, University of Heidelberg (Smola et al., 1993). Wild
type mouse fibroblasts were isolated from adult mice by outgrowth from explants of
back skin samples (Angstmann, 2007). Its counterparts double knock out mouse fibrob-
lasts isolated from newborn mice, deficient in nidogen-1 and nidogen-2 were generously
provided by R. Nischt, Cologne (Nischt et al., 2007).
3.2.3 The human epidermal cell line HaCaT
The human epidermal cell line HaCaT was developed from a long-term primary cul-
ture of human adult skin keratinocytes, isolated from non-affected skin of a 62 year old
melanoma male patient (Boukamp et al., 1988). Culturing in low calcium medium (0.2
mM) resulted in reduction of terminal differentiation of the keratinocytes. Furthermore,
elevation of culture temperature to 38.5℃ caused increased proliferation and prolonged
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the average life span, presumably by inducing genetic instability. Those modified culture
conditions led to a spontaneous, immortalized human keratinocyte line, still restoring
high differentiation potential while being not tumorigenic or invasive. At least in part,
immortalization was due to the later found independent, distinct mutations in the p53
gene in both alleles. The name HaCaT indicates the initial culture conditions for estab-
lishing the cell line: human, adult, low calcium, and elevated temperature. Based on
this immortalized cell line, HaCaT-ND1 cells, inducible in nidgogen-1 expression, were
generated. Upon addition of tetracycline using the T-REx-system (Invitrogen) the ex-
tracellular matrix protein nidogen-1 (also entactin) is expressed (Angstmann, 2007; Regl
et al., 2002; Yao et al., 1998).
3.3 Cell culture
All cells, mesenchymal stromal cells, HaCaT cell lines, mouse and human fibroblasts
were cultured under standard conditions in a humified atmosphere at 37℃, 5% CO2,
95% air.
Mesenchymal stromal cells were cultured in complete MSC-GM optimized for MSC
cultivation containing antibiotics. MSCs were split at about 80-90% confluency by
washing two times with phosphate buffered saline (PBS) and incubation with 0.1%
trypsin. The trypsin reaction was stopped by adding equal amounts of complete growth
medium. For subcultivation MSCs were seeded at densities of 2000 cells/cm2 in fresh cell
culture flasks. Skin derived keratinocytes and fibroblasts were cultured in 1x Dulbecco’s
modified eagle medium (DMEM) containing 10% fetal calf serum (FCS), 100 U/ml
penicillin and 100µ/ml streptomycin. Fibroblasts were split when reaching confluency
at a ration of 1:3 - 1:5 and HaCaT cells at a ratio of 1:10. To remove residual serum and
ECM with bound calcium and magnesium, fibroblasts were washed twice with 0.05%
EDTA while keratinocytes were incubated first in 0.05% EDTA for 15 minutes at room
temperature. Fibroblasts were detached by incubation with 0.1% trypsin at 37℃ for
3-5 minutes. HaCaT cells were incubated in 0.05% trypsin for about 7 minutes and
trypsin reaction was stopped by adding complete growth medium. For maintenance
of selection pressure on transfected HaCaT-ND1 cells medium was supplemented with
6 µg/ml Blasticidin S and 25 µg/ml Zeocin. For keratinocyte cultures designated for
nidogen expression, 1 µg/ml of the inducing agent doxcycline was added.
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3.3.1 Cell Counting
If desired, cells were counted using the automatic cell counter system CASY®-1. Rou-
tinely, 50 µl of trypsinized cell suspension were diluted 1:200 in isotonic CASYton
solution. Cell numbers were calculated by the CASY®-1 system automatically.
3.3.2 Cryopreservation of cells
Cells were detached from culture dishes as described above for regular subcultivation.
After inactivation of trypsin cell suspensions were centrifuged for 5 min at 1000 x g. The
supernatant was removed carefully and cell pellets were resuspend in freezing medium.
Keratinocytes and fibroblasts were frozen in 1xDMEM, 20% FCS, 10% glycerol at a
final concentration of 2 x 106 cells/ml. For MSCs final concentration was set to 0.5 x
106 cells/ml in FCS containing 20% DMSO. Aliquots of 1 ml were transferred into cryo-
tubes and pre-cooled for 1 h at 4℃. The freezing was performed gradually, decreasing
temperature 1℃ per minute in a freezing container. Frozen samples were stored in
liquid nitrogen. For recultivation, cells were thawed in a 37℃ water bath rapidly and
transferred immediately to a 100 mm culture dish containing complete growth medium.
To remove residual cryoprotectant medium was changed 24 h after thawing.
3.3.3 In vitro differentiation of MSCs
For gene and protein expression as well as histochemical analysis 3-4 x 103 cells/cm2 were
seeded and kept in MSC-GM for 24 hours. Adipogenic differentiation was induced in
confluent cultures by adipogenic induction medium, containing recombinant human in-
sulin, dexamethasone, indomethacin, and 3-isobutyl-l-methyl-xanthine (IBMX) (AIM).
Three days later, AIM was replaced by adipogenic maintenance medium lacking dexam-
ethasone, IBMX and indomethacine (AMM) for 2 days. After 3 induction/maintenance
cycles and 4-7 additional day in AMM, adipogenic differentiation was fully developed.
Uninduced control cultures were kept in MSC-GM throughout. For osteogenesis conflu-
ent cultures were incubated in osteogenic induction medium, containing dexamethasone,
ascorbate and β-glycerophosphate (OIM). Fresh OIM was added twice a week for 21
days, while negative controls were fed with MSC-GM on the same schedule.
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3.4 Impedance measurements
Measurements were done in two different systems, recording changes in electrical resis-
tance of cell layers on sensing gold electrodes (Atienza et al., 2005). Using the ECIS
Model 1600 and appropriate software, cells were analyzed in eight well-plates, each well
(0.8 cm2) with 40 electrodes of 250 µm diameter (ECIS 8W10E+ arrays). For mea-
surement an oscillator sets an AC signal of 1-V amplitude at a frequency of 45 kHz
in series with a 1 MΩ resistor resulting in an approximately constant current of 1 µA.
Measuring signals are obtained through a lock-in amplifier and impedance data are
collected at a computer. ECIS device allowed microscopic observation of samples, but
titration curves revealed that cells had to be seeded at high densities for effective mea-
surements. To improve cell attachment, wells were incubated with complete MSC-GM
for 4 hours. Medium was removed and 0.5 ml cell suspension was applied to each well
(0.5 - 1 x 105 cells/well equal to 0.6125 - 1.25 x 105 cells/cm2), suspending fibroblasts
or MSCs directly in differentiation media (AIM or OIM) or control media (MSC-GM).
Accordingly, for impedance data of keratinocyte cultures wells were preincubated with
DMEM, 10%FCS for 4 hours and cells were seeded at densities of 2 x 105 cells/well (2.5
x 105 cells/cm2). Directly after cell plating arrays were placed in an incubator (37℃,
5% CO2) and impedance was recorded in duplicate samples at 45 kHz. Secondly, the
xCELLigence RTCA DP instrument was employed. In this 3 x 16 well-device (E-Plate
16; 0.2 cm2/well), cell containments have a much higher electrode density covering 80%
of the surface area (Atienza et al., 2005). Here cell titration revealed that much lower
seeding densities were required, but light microscopy was not possible. Cell prepara-
tion and conditioning of xCELLigence wells was as described above except that 5 x 103
cells/well (2.5 x 104 cells/cm2) were seeded and first allowed to settle for 30 min at
room temperature (RT) before transfer to the incubator. Measurements were done in
quadruplicates at 50 kHz (37℃, 5% CO2).
For comparative analysis, ECIS impedance data were normalized by dividing recorded
impedance values by the impedance measured at time zero of recording or at the point
of adding induction media, respectively. Defining these reference values as 1.0, the later
time points indicate changes in the relative impedance which is dimensionless. Due to
the supplier-defined readout of the xCELLigence system the corresponding values had
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to be recalculated first, as detailed in 3.4.1, to obtain profiles which are comparable for
both systems.
3.4.1 Normalization of xCELLigence impedance data
The xCELLigence readout is defined by the manufacturer as "Cell Index"
CI = Rtn−Rt0F
with
Rt0 Background resistance measured at time point zero
Rtn Resistance measured at time point "n"
F Frequency dependent constant of the instrument
According to supplier’s information F is 15 Ω. Based on the background value Rt0
determined beforehand, Rtn can be calculated from the CI values for each measured
time point using the rearranged formula from above.
Rtn = CI ∗ F +Rt0
As for ECIS recording, normalized curves (relative impedance, dimensionless) were
obtained by dividing the recorded impedance values (Rtn) by the background impedance
at time zero (Rt0), so by definition the relative impedance at time point zero is again
1.0.
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3.5 Coating of ECM-proteins
Cell adhesion, growth and differentiation was monitored on the extracellular matrix
proteins collagen type I, collagen type IV, fibronectin, and laminin. For stock solutions
collagens were dissolved in 0.2% sterile acetic acid (2 mg/ml) over night at 4℃ and fi-
bronectin in sterile water (1 mg/ml), while laminin was supplied in solution (0.5 mg/ml).
For denaturing of type I collagen, stock solution of collagen I was heated to 56℃ for
8 hours. For impedance measurements, the wells of E-plate 16 were coated with 100
µl/cm2 of 50 µg/ml protein in PBS at RT for 45 minutes (corresponding to 5 µg/cm2),
adding plain PBS to control wells. Liquids were aspirated, wells washed twice with
PBS, and cells plated on freshly coated, non-dried surfaces, measuring impedance in
quadruplicates. For comparison cells were seeded on coated cover slips at comparable
densities.
3.6 Multiple Substrate Array
Cell attachment on a variety of ECM proteins was determined on multiple substrate
arrays (MSA). The assembled culture devices contain 14 wells with the proteins col-
lagens I-VI, laminin, fibronectin (all those from different tissue sources), vitronectin,
and heparan sulfate proteoglycan, each microspotted in quadruplicates on a glass sur-
face. To evaluate the influence of differentiation media on cell adhesion and spreading
1 x 104 BMSCs per well were seeded on MSA slides in AIM, OIM, and in MSC-GM
as control. For comparison fibroblasts and HaCaT cells were seeded on MSA slides
in DMEM, 10% FCS. After 4 hours incubation at 37℃ (95% air, 5% CO2) cells were
washed in PBS, fixed with 3.7% formaldehyde and further processed for staining and
immunofluorescence as described in 3.8.
3.7 Migration assays
For migration studies, cells were seeded in duplicates as described above in ECIS 8W1E
arrays containing only one central single sensing electrode (250 µm diameter) in each
well (Keese et al., 2004). 5 x 104 MSCs and fibroblasts or 2 x 105 keratinocytes were
seeded and grown to plateau values of impedance recordings. These confluent cell layers
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were wounded by a pulse of 4V (45 kHz) for 20 seconds for MSCs and fibroblasts or
3 times 20 second pulses for keratinocyte cultures, respectively, causing complete cell
detachment from the electrode. Recordings were resumed immediately after the pulse to
monitor repopulation of the wounded area. To study the influence of soluble factors on
migration, media were supplemented with 100 ng/ml SDF-1, 10 ng/ml platelet derived
growth factor (PDGF)-AB or 50 ng/ml tumor necrosis factor α (TNFα), respectively.
In parallel, µ-slides equipped with removable silicon-inserts providing two separated
growth areas were used. 8,000 cells per insert well were seeded and after reaching
confluency, silicon inserts were removed to allow cells to migrate into the artificial
cell-free gap. To document closing of the gap, microscopy pictures were taken every
24 hours and newly populated area was determined by image analysis using ImageJ
software (http://rsbweb.nih.gov/ij/).
3.8 Light microscopy and immunofluorescence
Cells grown on cover slips or in ECIS arrays were fixed with 3.7% formaldehyde for
15 minutes, washed with dH2O and treated with 0.5% Triton X-100 for 5 minutes.
After two washes with PBS, samples were blocked in blocking buffer composed of 5%
BSA, 0.02% Tween20 in PBS, and then incubated with guinea pig antibodies against
vimentin or keratin (1:100) in 2% BSA for 90 minutes at RT. After three washes in
PBS and incubation in blocking buffer for 15 minutes, Cy3-labeled secondary donkey
antibodies against guinea pig, were applied for 45 minutes in the dark, together with
Hoechst 33258 (1:50) for nuclear staining. For actin filament staining, samples were
incubated with FITC-conjugated phalloidin (1:50 dilution). After three washes in PBS
for 10 minutes samples were covered with mounting medium.
For staining of lipid droplets, fixed samples were washed in 60% isopropanol for 3
minutes and stained for 5 minutes in Oil Red O (ORO) in isopropanol. Therefore,
three parts of ORO stock solution I were diluted with two parts of dH2O, filtrated
through whatman paper. Excessive dye was removed and samples washed in tap water
several times. Nuclei were counterstained in hematoxylin solution for 5 minutes and
samples were washed again in tap water until wash solution remained clear. ORO
staining protocol was modified for fluorescence detection of lipid droplets as reported
previously (Koopman et al., 2001). Three parts of ORO stock solution II were diluted
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with 2 parts of dH2O, filtrated through whatman paper. Before mounting, processed
immunofluorescence samples were incubated with ORO stain for 30 minutes, rinsed with
dH2O and finally under running tap water for 10 minutes. Pictures were taken with a
Leica DM RD microscope equipped with Analysis software (Olympus).
Osteogenic differentiation was determined by staining fixed cells with 40 mM Alizarin
red S, pH 4.1 for 20 minutes (Gregory et al., 2004). Samples were washed four times
with dH2O for 5 minutes and micrographs taken as above. Alternatively, for osteogenic
von Kossa staining (Majumdar et al., 1998) fixed samples were incubated in 5% silver
nitrate for 15 min, 2 times washing in dH2O before developping in 1% pyrogallol solution
for 5 min in the dark, washed twice with dH2O and fixated in 5% sodium thiosulfate for
5 minutes. The intensity of red ORO or Alizarin staining was evaluated together with
nuclear Hoechst stain in 21 day cultures using ImageJ software. At least 10 pictures
were analyzed and statistical significance was determined by Student’s t-test.
3.9 Protein analysis
For protein extraction, MSCs grown in the different media (MSC-GM, adiopgenic in-
duction medium (AIM), osteogenic induction medium (OIM)) were harvested at day 0,
2, 5 and 14. After washing with ice-cold PBS, cells were scraped with a cell lifter and
centrifuged for 5 min at 250 x g, 4℃. Cell pellets were suspended in lysis buffer, supple-
mented with protease inhibitors and incubated on ice for 60 minutes. Cell debris was
removed by centrifugation for 10 min at 10,000 x g, 4℃ and supernatant was transfered
into a new vial. Protein concentrations were determined by colorimetric assay accord-
ing to Bradford. The protein content of protein lysates was calculated from a standard
BSA curve as reference, covering the range of 0-4 µg/ml protein. The standards and
1:10 diluted samples with Bradford reagent were measured in a spectrophotometer at
595 nm.
Total protein (100 µg) was mixed with sample loading buffer, heated at 95℃ for 5
minutes and proteins were separated by electrophoresis in a 10% SDS-polyacrylamide
gel. Proteins were transferred onto nitrocellulose membranes and protein transfer was
checked with Ponceau S. Ponceau was removed by washing in blocking buffer and after
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additional blocking for 1-2 hours, membranes were incubated with primary antibod-
ies (guinea pig anti-perilipin, mouse anti-adipophilin, mouse anti bone sialoprotein,
rabbit anti-osteopontin) at 4℃ over night. Unbound primary antibodies were re-
moved by 3 times washing in blocking buffer for 10 minutes before incubation with
peroxidase (POX)-conjugated secondary antibodies for 45 minutes at RT. Enhanced
chemiluminescence (ECL) reaction was detected on x-ray films, developed in an AGFA
film processor.
Mouse wild-type fibroblasts and keratinocytes, 3 days induced for nidogen-1 expres-
sion and uninduced controls were lysed as described above and 30 µg of total protein
were separated in a 6% SDS-polyacrylamide gel. After protein transfer and blocking,
membranes were incubated with rabbit anti-nidogen-1 antibody and detected with anti-
rabbit POX-conjugated secondary antibodies. For loading controls bound antibodies
were removed by incubation in 62.5 mM Tris, pH 6.7, 2% SDS, 1% β-mercaptoethanol
at 56℃ for 10 minutes followed by several washing steps with blocking buffer to remove
residues of β-mercaptoethanol. Membranes were incubated with rabbit anti-β actin or
mouse anti-β-tubulin antibodies and detected as above.
29
3.10 Gene expression analysis
3.10 Gene expression analysis
For isolation of RNA, cells were lysed in 350 µl RLT buffer containing 1% β-mercaptoethanol
and RNA was isolated using the RNeasy Mini Kit from QIAgen. Concentrations of iso-
lated RNA samples were determined using a NanoDrop fluorospectrometer.
3.10.1 PCR for nidogen-1 gene expression
Reagents for reverese transcription were from the Omniscript RT Kit. Two µg of RNA
were incubated in 1x reverse transcription buffer, containing 0.5 mM of dNTP mix, 1
µM Oligo-dTs, 4 U Omniscript RT enzyme, and 10 U RNase-Inhibitor in a total volume
of 20 µl. Reverse transcription reaction was carried out in a thermal cycler at 37℃ for
60 minutes. For detection of nidogen-1 gene expression, 2 µl of reverse transcriptase
reaction were used in 1x CoralLoad PCR buffer containing 1.5 mM MgCl2, 0.2 mM
of each dNTP, 0.4 µM of each primer (table 3.6) and 1.5 U Taq DNA polymerase.
Conditions of PCR are described in tabel 3.7. PCR-product was separated in a 2%
agarose gel in 1xTAE buffer, containing 1:10000 SYBR Safe and detected using an UV
illuminator.
Table 3.6: Nidogen-1 primer
Primer Sequence
Forward 5’-TGG CAG CAG AGT ATG TCC AG
Reverse 5’-GCT CCG TTG CTC TTC CAT AG
Table 3.7: PCR program
Temperature [℃] Time Cycles
Pre-incubation 95 5 min 1
95 1 min
Amplification 60 45 s 35
72 1 min
Extension 72 10 min 1
Cooling 4 ∞
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3.10.2 RT-qPCR of adipogenic marker genes
The relative expression of adipogenic marker genes (table 3.9) was analyzed after 24, 48
and 72 h, as well as 5, 7 and 14 days. One µg RNA was reverse transcribed using 2.5 µM
anchored-oligo(dT)18 primer and the Transcriptor High Fidelity cDNA Synthesis Kit.
For RT-qPCR a 20 µl reaction mix of 50 ng transcribed RNA, 0.2 µM primer and 0.1
µM probe (table 3.9) and 10 µl Light Cycler 480 Probes Master was applied to a Light
Cycler 480 as indicated in table 3.8. Three genes (table 3.9), identified with geNorm
(http://medgen.ugent.be/∼jvdesomp/genorm/index.php) as the most stable expressed
genes out of five tested, were taken to calculate a normalization factor. Primer efficiency
has been determined and relative expression based on efficiency and the normalization
factor was calculated as described in (Vandesompele et al., 2002). A cDNA mix of three
adipocyte samples served as positive control to normalize PCR plates and RNase-free
water as negative control.
Table 3.8: RT-qPCR program
Temperature [℃] Time Ramp rate [℃/s] Cycles
Pre-incubation 95 10 min 4,8 1
95 10 s 4,8
Amplification 60 30 s 2,2 45
72 1 s 4,4
Cooling 40 10 s 1,5 1
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Table 3.9: Primer sequences with specified probe numbers
Gene Primer sequence Probe 1
TATA box binding protein (TBP) 2 F: 5’-cccatgactcccatgacc-3’ 51
R: 5’-tttacaaccaagattcactgtgg-3’
beta-2-microglobulin (B2M) 2 F: 5’- ttctggcctggaggctatc-3’ 42
R: 5’-tcaggaaatttgactttccattc-3’
glyceraldehyde-3-phosphate F: 5’-tccactggcgtcttcacc-3’ 45
dehydrogenase (GAPDH) 2 R: 5’-ggcagagatgatgaccctttt-3’
peroxisome proliferative activated F: 5’-caggaaagacaacagacaaatca-3’ 7
receptor γ (PPARγ) R: 5’-ggggtgatgtgtttgaacttg-3’
perilipin F: 5’-ggacacagtggtgcattacg-3’ 64
R: 5’-gtcccggaattcgctctc-3’
adiponectin (ADPQ) F: 5’-ggtgagaagggtgagaaagga-3’ 85
R: 5’-tttcaccgatgtctcccttag-3’
1 Human Universal Probe Library (Roche)
2 Reference genes
F, forward; R, reverse
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4.1 Discrimination between cell type and cell number by
impedance monitoring
To optimize conditions for impedance measurements different cell types were seeded at
various densities. Immortalized human keratinocytes, skin derived human fibroblasts
and human mesenchymal stem cells were used. Direct correlation with cell morphology
was made in the electric cell-substrate impedance sensing (ECIS) system (see methods
3.4). The impedance recordings (xCELLigence) revealed nearly complete saturation for
BMSCs at a seeding density of 5 x 103 cells/well (2.5 x 104 cells/cm2), only marginally
increasing at higher cell densities (Fig. 4.1). After an initial very rapid increase which
matched with nearly full cell spreading within the first 4 hours (Fig. 4.2), at 10 hours
curves tended to decrease, rising slowly but steadily again after approximately 24 hours
(Fig.4.1 A). Seeding 2.5 x 104 fibroblasts/cm2 showed a comparable peak, while the
maximum was nearly doubled with 5 x 104 cells/cm2, profiles declining later on to a
lower plateau depending on the initial cell number (Fig. 4.1 B). With similar numbers of
HaCaT cells (5 x 104 cells/cm2) impedance rose markedly slower and reached plateaus
with considerable delay after 45 hours (Fig. 4.1 C), well correlating to generally slower
and less intense spreading of keratinocytes (Fig. 4.2). Thus, by plating more HaCaT
cells sensing electrodes were covered within 5 to 10 hours giving rise to strong impedance
values. This emphasizes that both cell number and spreading or morphology strongly
influence impedance profiles. But the smaller surface and higher coverage with gold
electrodes in the xCELLigence system allowed lower cell seeding (factor 10-20) and
thus was used for statistical analysis. The ECIS system (cell titration not shown) in
contrast allows the direct correlation with cell morphology and thus was used to monitor
differentiation by cellular staining after recording.
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Figure 4.1: Cell density and cell type affect impedance profiles - For optimizing
impedance measurements BMSCs (A), fibroblasts (B) and keratinocytes (C) were seeded
at various densities in growth medium. Impedance profiles of means of quadruplicates
(normalized values) were recorded continuously over 60 h (xCELLigence system).
For evalutation of cell morphology and spreading cells were seeded on protein spots
(MSA-Slide). After 4 hours cells were stained for actin and vimentin or keratin, revealing
generally good attachment and spreading of BMSCs and fibroblasts (both vimentin
positive) on most ECM components (shown for collagen I; Fig. 4.2 A and B). For
keratinocytes (stained for keratin) spreading was minimal at this point throughout (Fig.
4.2 C). Spreading of cells corresponded to impedance profiles which were less steep for
keratinocytes compared to bone marrow derived mesenchymal stromal cell (BMSC)s
and fibroblasts (Fig. 4.1).
Actin - Vimentin - Hoechst Actin - Vimentin - Hoechst Actin - Keratin - Hoechst
Figure 4.2: Attachment of cells on MSA - Attachment of BMSCs (A), fibroblasts
(B) and keratinocytes (C) on rat tail collagen I spot (MSA-slide). 1 x 104 cells per MSA-
well after incubation for 4 hours at 37℃. All cells were stained for actin-filaments (green),
BMSCs and fibroblasts were stained for vimentin (red) (A and B) or keratinocytes for
cytokeratine (red) (C). Nuclei, Hoechst dye (blue); scale bar = 50µm.
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4.1.1 Monitoring changes in cell adhesion
To show cell adhesion effects on impedance measurement cells with altered expression of
adhesion molecule were used in ECIS-system. HaCaT keratinocytes, naturally negative
for nidogen expression, were stably transfected with the Tet-on system (Invitrogen)
for inducible nidogen expression (Angstmann, 2007). For impedance measurements
2.5 x 105 cells per cm2 were seeded and nidogen-1 expression was induced by addition
of doxycycline. As controls non-induced cells were measured in parallel. Induction of
nidogen-1 led to an increasing slope of impedance compared to not-induced nidogen-
1 cells, indicating for changed adhesion properties of the cells in response to nidogen
expression (Fig. 4.3).
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Figure 4.3: Impedance profiles of nidogen-inducible cells. - Nidogen-1 expressing
cells (green line) show steeper profile compared to not-induced nidogen-1 transfected cells
(red).
4.1.1.1 Confirmation of molecular switch by gene and protein expression analysis
For confirmation of nidogen expression in stable transfected HaCaT cells, gene and pro-
tein expression of nidogen-1 were verified by PCR and western blot analysis, as well as
immunofluorescence staining of cultured cells. Although clones from single cell colonies
were selected, heterogeneous not selected cell populations of stable transfected cells
showed best expression of nidogen-1 compared to clonal cells (not shown). Nidogen-
1 gene expression could be demonstrated by PCR revealing positive detection of 307
bp nidogen-1 product in induced cells (Fig. 4.4 A). Inducible expression of nidogen
protein was shown in western blot experiments and immunofluorescence staining of cul-
tivated cells. Western blot experiments showed hardly detectable nidogen-1 expression
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in selected ND1-clones but was clearly detectable in unselected cultures (Fig. 4.4 B).
Nidogen-1 expressing cells were stained for cytoskeleton protein actin (Phalloidin stain)
and nidogen-1. As shown previously (Angstmann, 2007) nidogen was not expressed in
all cells but nidogen is expressed in positive clusters (Fig. 4.4 C).
dko +_wt
ND1
TUB
wt - +
A C
Actin - Nidogen - Hoechst
B
Figure 4.4: Expression of nidogen - (A) PCR of cDNA from wild-type mouse fibrob-
lasts (wt) and induced HaCaT cells (+) showing nidogen-1 gene expression while samples
from mouse with total knock out of nidogen expression (dko) and not induced HaCaT
cells (-) were negative. (B) Western blot data confirmed nidogen-1 (ND1) protein expres-
sion in samples from wild-type mouse fibroblasts (wt) and induced keratinocyte cells (+),
which was not detectable in not induced keratinocytes (-); loading control stained for β-
tubulin (TUB) below. (C) Immunofluorescence staining for filamenteous actin (Phalloidin,
green) and nidogen-1 (red) showing heterogeneous nidogen expression in induced HaCaT
populations. Nuclei counterstained with hoechst dye (blue); scale bar: 25 µm.
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4.2 Monitoring of MSC differentiation
4.2.1 Differentiation potential of MSCs is dependent on passage number
In order to follow early changes after induction of differentiation, BMSCs (passage
6), suspended in adiopgenic induction medium (AIM), osteogenic induction medium
(OIM) or mesenchymal stem cell growth medium (MSC-GM) (two samples each) were
seeded on ECIS chips at a density of 0.5 - 1 x 105 cells/well (0.6125 - 1.25 x 105
cells/cm2) and impedance was monitored over 25 hours (Fig. 4.5). Over the first 5-8
hours impedance strongly increased under any conditions, though for cultures in AIM
the slope was less steep (Fig. 4.5 A). After this early phase, profiles of osteogenic
cells remained at a constant plateau, whereas those of adipogenic or non-induced cells
decreased. Contrarily, the profiles of later BMSC passages (p15) did not substantially
differ between AIM, OIM, and control media (Fig. 4.5 B).
A B
Figure 4.5: MSC differentiation induces early and specific changes in impedance
Impedance of low (A) and high passaged (B; population doublings higher 25) BMSCs in
AIM (blue line), OIM (red), MSC-GM (black) and growth medium without cells (green).
4.2.2 Induction of differentation reflected by impedance
Seeding cells (p6) in GM and adding OIM or AIM after 3.5 hours indicated early in-
fluences of induction media, independent of initial cell adhesion (Fig. 4.6 A). While
adipogenic induced cells develop less steep profiles as already seen before (Fig. 4.5
A) immediately after adding differentiation factors, slopes of osteogenic induction and
control medium increased faster initially. In further progress, osteogenic cells remained
at high level or are further increasing impedance while profiles of adipogenic induction
and control medium declined. In vitro differentiation of MSCs is based on addition of
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specific factors into the cell culture medium which induce the process of differentiation
(see 1.1.1 and 3.3.3). Culturing of MSCs in adipogenic medium lacking one of these fac-
tors produce impedance profiles reflected the importance of these factors in adipogenic
differentiation (Fig. 4.6 B). While lack of dexamethasone or insulin resulted in still
declining impedance profiles similar to differentiation medium containing complete set
of differentiation factors, whereas the lack of indomethacine or IBMX showed profiles
with a steeper initial slope without the adipogenic typical decrease resembling more the
profile of growth medium without any differentation factors.
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Figure 4.6: Induction of MSC differentiation - (A) Profiles of differentiating MSCs
diverged after adding medium containing differentiation factors (arrow) to pre-plated BM-
SCs (p6). Differentiation was induced in AIM (blue line), OIM (red) and controls were
cultured in MSC-GM (black). Graphs were normalized to the time point of induction, (B)
BMSCs seeded in adipogenic differentiation medium lacking single factors usually included
for differentiation: AIM without IBMX (green), without Indomethacine (purple), without
dexamethasone (light blue) and without insulin (red). Controls of complete adipogenic
differentiation medium in blue and growth medium in black.
4.2.3 MSCs behavior depends on donor tissue
To monitor MSC differentation from different tissues in long-term experiments, impedance
was recorded for 14 days with BMSCs and ASCs from three and two donors, respec-
tively. Cells were kept in MSC-GM for 26 hours before adding differentiation media
(Fig. 4.7). Overlapping impedance profiles diverged after induction revealing typically
a steeper slope in OIM, delayed slope in GM, and no increase rather than a decrease
in AIM. With repeating adipogenic induction cycles the impedance profiles showed al-
ternating a steep increase with subsequent plateau in adipogenic maintenance medium
and in turn a decrease after adding AIM. Plain media effects could be excluded by
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impedance measurements without cells (not shown). The more advanced profiles of
BMSC-1, -2, -3 (Fig. 4.7 A; mean of three), and ASC-2 (Fig. 4.7 D) exhibited signifi-
cant differences between osteogenic, adipogenic, and non-induced cells. But for ASC-1
(Fig. 4.7 C) osteogenic and control profiles were largely overlapping. BMSCs cultivated
in vitro for more than 25 population doublings (p13) did not show the typical impedance
profiles when exposed to differentiation medium (Fig. 4.7 B). Neither the continuously
rising osteogenic profile even declining profile after initial peak, nor typical alternating
impedance profile seen before during adipogenic differentiation were developed during
differentiation of in vitro aged MSCs.
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Figure 4.7: MSC differentiation from different sources - Impedance profiles of (A)
low passaged BMSCs (mean of three donors), (C) ASC-1 and (D) ASC-2 (all ECIS system)
compared to (B) high passaged BMSC in xCELLigence system recorded in duplicates for
14 days; Inducing differentiation after 26h, or immediately (B), (OIM: red line; AIM: blue)
and non-induced controls (black); profiles over at least 10 days after induction. Medium
changes are indicated by arrows, the switch from AIM to AMM is marked by black and
back to AIM by white arrows.
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4.2.4 Confirmation of impedance data by specific staining, protein and
RNA analysis
To correlate impedance to cell number and morphology cultures were examined by
microscopy. Staining at the endpoint (day 5) for actin filaments and cell nuclei showed
that cells completely covered the electrodes in all media (Fig. 4.8 A-C). Seeding identical
cell numbers in all media at high densities producing confluent cell layers immediately
after seeding minimized differences of impedance values which are due to cell numbers
but mainly reflects cell morpholoy and adhesion properties.
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Figure 4.8: Cells on electrodes - Fluorescence microscopy of differentiating BMSCs on
ECIS electrodes (red circles) after growth for 5 days in MSC-GM, AIM and OIM. Staining
of actin filaments with phalloidin-FITC (green) and of cell nuclei (blue; Hoechst). Scale
bar: 50 µm. (D) Cell numbers of BMSCs on ECIS electrodes after 5 days in MSC-GM,
AIM and OIM determined by counting of Hoechst dye stained cell nuclei.
Determination of cell numbers on electrodes after cultivating cells for 5 days did show
only neglitable, not significant variations of cells on the electrodes between the different
media (Fig. 4.8 D). Generally, cell densities appeared slightly higher on gold than on the
plastic surface, though reliable evaluation was hampered by the different plane of focus.
While in MSC-GM cells were more spread than in AIM or OIM, apparent by flattened
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nuclei and an extended actin cytoskeleton, in AIM cells appeared smaller and more
roundish. The actin network was most pronounced in OIM revealing predominantly
spindle shaped, often overlapping cells, whereas the heterogeneous morphology in MSC-
GM was accompanied by sparser actin filaments.
Importantly, the impedance profiles fully corresponded to the differentiation levels at
day 14, indicated by Oil Red lipid stain or mineralization (mainly calcium phosphates)
by von Kossa stain and molecular markers (Fig. 4.9). While ORO was strongly positive
throughout (Fig. 4.9 A-C), ASC-1 kept in OIM revealed at best marginal von Kossa
staining (Fig. Fig. 4.9 F) compared to deposited calcium stained in BMSCs and ASC-2
samples (Fig. 4.9 E and G).
A B C D
E F G H
Figure 4.9: ORO and von Kossa stain of BMSCs and ASCs - ORO (A-D) and von
Kossa (E-H) staining in ECIS-wells, respectively at end point (d14), for BMSCs (A, E),
ASC-1 (B, F) and ASC-2 (C, G); negative controls shown for ASC-2 (D, H). Scale bar:
100 µm.
Western blots confirmed the actual course of differentiation at the protein level, as
exemplified for BMSCs (ASC-2 similar, not shown), by detection of adipose differen-
tiation related protein (ADRP) and perilipin (PERI) for adipogenic differentiation or
late osteogenic marker bone sialoprotein (BSP) and osteopontin (OPN) for osteogenic
differentiation (Mizuno and Kuboki, 2001), respectively (Fig. 4.10). Validating the
value of impedance as measure for differentiation, in ASC-1 the low osteogenic profile
(compare Fig. 4.7) correlated also to low expression of the osteogenic markers BSP and
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osteopontin.
BSP
PERI
ADRP
OPN
BMSC ASC
ACT
GM AIM GM AIM
GM OIM GM OIM
Figure 4.10: Western blot of differentiated MSCs - Western blots of 14 days cultures
(induced vs. uninduced) showing adipophilin (ADRP) and perilipin (PERI) as adipogenic
marker and for osteogenic differentiation bone sialoproten (BSP) and osteopontin (OPN)
with β-actin (ACT) as loading control for the BMSC and the ASC-1 samples. Note that
low OIM profile of ASC-1 corresponds to only marginal von Kossa stain and low BSP and
osteopontin.
Specificity of adipogenic differentiation was underlined by RNA data (RT-qPCR) from
cultures grown in alternating AIM and AMM, corresponding to significant time points
of impedance profiles. This revealed a marked AIM-dependent induction of peroxisome
proliferative activated receptor (PPAR)γ, and also for perilipin shown for samples of
BMSC-1, -2, and -3 and ASC-1 (Fig. 4.11 A and B), which was inversely related to the
oscillating impedance signals. Gene expression of late adipogenic marker adiponectin
was highly expressed in all samples only in 14 day AIM-cultures (Fig. 4.11 C). The
expression of all examined adipogenic differentiation related genes was quite variable
between the samples, in general. RT-qPCR of osteogenic genes did not give reliable
results although several primers and probes and combination of them have been tested.
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Figure 4.11: Adipogenic gene expression of BMSCs and ASCs - Relative gene
expression (induced minus uninduced) of adipogenic markers (A) PPARγ, (B) perilipin
and (C) adiponectin at different timepoints of the 3 different BMSC isolates (days 1, 2, 3,
5, 7 and 14) and ASC-1 (days 2, 5 and 14). After 3 days, induction medium was switched
to maintenance medium (black arrow) and back to AIM again (white arrow), indicating
the effect of induction/maintenance medium, obvious also in impedance profiles. All cells
have been analyzed at population doublings below 20.
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4.3 Cell adhesion on ECM proteins monitored by
impedance measurements
Next the influence of interactions with proteins of the ECM on MSC behavior with
consequences on impedance profiles was examined.
4.3.1 Extracellular matrix proteins affect MSC differentiation
For studying differentiation of MSCs on ECM proteins, BMSCs were cultured in vessels
coated with collagen I, collagen IV, fibronectin or laminin. Seeding 2.5 x 104 cells/well
(xCELLigence) impedance was measured for 96 hours (Fig. 4.12). Osteogenic induction
caused steeply rising impedance profiles on collagen I or IV, while reaching markedly
lower values with somewhat flattened slopes on fibronectin and particularly laminin,
correlating to early morphological appearance of the cells (see also 4.16 and 4.17).
Beyond 20 hours the shape of osteogenic curves was similar. Showing an almost as strong
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Figure 4.12: Extracellular matrix molecules influence impedance differentiation
profiles of MSC - Impedance profiles of differentiating BMSCs on various ECM coatings:
2.5 x 104 cells/cm2 were seeded on collagen I, collagen IV, fibronectin and laminin. Profiles
are means of quadruplicates in differentiation media (OIM: red, AIM: blue) and control
medium (black).
increase on the collagens, the adipogenic impedance profiles dropped on all matrices to
levels far below the endpoints of osteogenic tracks. However, the initial reduction of
the adipogenic curve was much less pronounced on fibronectin, exceeding the largely
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reduced osteogenic profile for about 30 hours, before it dropped below the osteogenic
profile which was steadily increasing. On laminin both curves reached similar, but
further reduced levels while their shapes corresponded to those on fibronectin. Skin
fibroblasts did not show very distinct profiles on those matrices in the various media,
though the initial attachment peak was highest on collagens (Fig. 4.13 A and B) and
markedly reduced on fibronectin in osteogenic medium (Fig. 4.13 C and D).
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Figure 4.13: Fibroblasts on extracellular matrix molecules monitored via
impedance - Impedance profiles of fibroblasts on various ECM coatings: 2.5 x 104
cells/cm2 were seeded on (A) collagen I, (B) collagen IV, (C) fibronectin and (D) laminin.
Profiles are means of quadruplicates in differentiation media (OIM: red, AIM: blue) and
control medium (black) (xCELLigence system).
4.3.1.1 Adhesion on Collagen I depends on coating density
Impedance profiles of BMSCs were also affected by coating with different concentrations
of collagen I. Adipogenic and osteogenic differentiation of BMSCs was induced in ECIS
wells coated with 5, 10, 25 and 50 µg/cm2 collagen I and impedance was recorded as
described before. Impedance values rose with rising collagen I concentration peaking at
25 µg/cm2 throughout all media and was very low for high concentration of 50 µg/cm2
suggesting inhibiting influences on cell adhesion due to dense collagen coating. While
in MSC-GM and AIM uncoated controls (Fig. 4.14 A and B) were quite similar to
10-25 µg/cm2 coated samples, for osteogenic differentiation impedance of samples are
in sequential order to rising collagen concentration, excepting highest collagen density
45
4.3 Cell adhesion on ECM proteins monitored by impedance measurements
of 50 µg/cm2, suggesting a supportive role of collagen I for adhesion of osteogenic cells.
Quantification of lipid accumulation with Oil Red revealed further influence of collagen
I on adipogenic differentiation of BMSCs being highest at 10 µg/cm2, somewhat lower
at 5 and 25 µg/cm2 and low at 50 µg/cm2 collagen I. High impedance values on 25
µg/cm2 in AIM (Fig. 4.14 B) inversely correspond to low ORO staining after 5 days
(Fig. 4.20).
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Figure 4.14: Concentration of collagen I affects impedance profiles - BMSCs were
seeded on various collagen I concentration (5 (green), 10 (purple), 25 (orange) and 50 (gray)
µg/cm2) in AIM (B) and OIM (C) differentiation media and MSC-GM (A) as controls.
Controls in uncoated wells were run in parallel in MSC-GM (A, black line), AIM (B, blue)
and OIM (C, red).
To evaluate the influence of conformational state of proteins, wells were coated with
collagen I in its native form as before, neither denatured nor being air-dried, and in
contrast with collagen I which has been denatured by heating before coating. Impedance
data of both conformations display similar profiles, where denatured collagen I resulted
in higher initial peaks and higher impedance values in general compared to native
collagen I (Fig. 4.15).
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Figure 4.15: Denatured vs. native collagen I coating in impedance measure-
ment - BMSCs were seeded in adipogenic (blue colors) and osteogenic (red colors) differ-
entiation and control media (black or gray) on native and denatured collagen I coated wells.
Impedance data of both conformations display similar profiles, with denatured collagen I
having higher impedance values in general (AIM: light blue; OIM: orange; MSC-GM: gray,
compared to native collagen I (AIM: blue; OIM: red; MSC-GM: black).
4.3.2 Confirmation and quantification of adipogenesis and osteogenesis
As possible morphological correlates phase contrast images of BMSCs revealed at 8
hours well spread cells without noticeable differences between applied media or matrices
(Fig. 4.16 A, D, G and J). While after 24 hours spindle shaped morphology was largely
retained, adipogenic cells showed prominent extensions and osteogenic cells markedly
increased in density (Fig. 4.16 B, E, H and K). The differences became more striking at
day 5, some cells in AIM containing also small lipid inclusion bodies (Fig. 4.16 C and F).
These morphological manifestations were similarly seen on collagen I and fibronectin.
Additionally, for evaluation of cell morphology at early time points, cells suspended
in the various media were plated on MSA containing ten different micro-spotted ECM
proteins. After 4 hours cells were stained for actin and vimentin. Shape and quantity
of attached BMSCs were further affected by differentiation media (examples of collagen
I, collagen IV and fibronectin are shown in Fig. 4.17). While in GM high numbers of
compact BMSCs were found on both collagens, on collagen I cells were widely spread in
AIM and OIM. On collagen IV the attachment rate was higher, cells appearing smaller
in OIM, much like in GM. By contrast, on fibronectin much fewer cells being extremely
spread attached in all three media.
Adipogenic and osteogenic differentiation markers were determined for BMSCs grow-
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Figure 4.16: Phase contrast microscopy of BMSCs on ECM proteins - BMSCs
were seeded on Collagen Type I and fibronectin in differentiation media and photos were
taken after 8, 24 and 120 hours. Scale bar: 100 µm.
Figure 4.17: Attachment of BMSCs on MSA on different ECM-proteins - After
incubation with 1 x 104 MSCs per well for 4 hours at 37℃ cells were stained for actin
(green), vimentin (red) and nuclei (blue; Hoechst dye). Cells on collagen I (left panel),
collagen IV (middle) and fibronectin (right) were grown in GM, AIM and OIM; scale bar:
100 µm.
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ing on ECM-coated cover slips. Five days after induction by AIM the highest number
of cells with lipid droplets (ORO staining) was observed on fibronectin and collagen I
followed by collagen IV, and being lowest on laminin (Fig. 4.18).
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Figure 4.18: Matrix influence on early adipogenic differentiation - Fluorescence
microscopy of adipogenic differentiation of BMSCs on ECM proteins 5 days after induction
(A-D), showing ORO positive lipid droplets (nuclei, Hoechst stain) compared to controls
(E-H); scale bar: 50 µm. (I) Histogram of percentage of positive cells (induced vs. unin-
duced) on various ECM coatings is at this stage already significantly different from controls.
Fibroblast staining does not exceed levels of controls (* p<0.05; ** p<0.01; *** p<0.001;
n=10).
But after 21 days positive cells rose to more than 80% on fibronectin and laminin,
compared to about 60% on collagen I and IV showing also less lipid accumulations.
Unexpectedly, without coating (PBS control) nearly 80% of cells were finally ORO pos-
itive presumably for soluble fibronectin and vitronectin in the media, firmly adhering to
glass surfaces. These results were corroborated by strongly increased staining intensity
at 21 days (Fig. 4.19 A-L) and image analysis which revealed a significantly stronger
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signal on fibronectin compared to the other samples (Fig. 4.19 M). The staining of the
high passaged BMSC (p16) was very low like seen in fibroblasts (compare Fig. 4.18).
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Figure 4.19: ORO staining of d21 samples - Fluorescence microscopy of lipid ORO
staining (nuclei counterstained) of BMSCs after 21 days in AIM and control medium (Ctrl)
cultivated on collagen I (A and B), collagen IV (E and F), fibronectin (I and J), laminin
(C and D) and controls without protein coating (G and H) as well as high passaged (P16)
cells (K and L); scale bar 50 µm. Intensity of ORO staining of BMSCs determined by
image analysis. Intensity was significant higher on induced fibronectin samples compared
to other matrices. High passaged MSCs showed significantly reduced intensity (* p<0.05;
** p<0.01; *** p<0.001; n=10).
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Intensities of ORO staining of BMSCs 5 days after adipogenic induction on various
collagen I concentrations (0-50 µg/cm2) did not differ significantly. However, after 21
days of adipogenesis, ORO intensity of uncoated controls exceeded that of collagen
I coated samples, which exhibit decreasing lipid staining when coating density was
increased (Fig. 4.20).
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Figure 4.20: Quantification of ORO staining on various collagen I concentrations
ORO staining of BMSCs differentiated into adipogenic cells was quantified after 5 and 21
days revealing influences of collagen I concentration on lipid accumulation in adipogenic
cells.
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Generally, the visible appearance of osteogenic markers took considerably more time.
After 21 days in OIM cells showed distinct staining of calcium deposits on collagens, in
general, partially less intense on collagen I, whereas staining was weaker on fibronectin
and laminin (Fig. 4.21). This was compatible with the more pronounced impedance
profiles of BMSCs on collagens in OIM (shown in Fig. 4.12). Although by and large
reflecting microscopic observations, differences seen in quantification of Alizarin staining
are not significant due to a very heterogeneous deposition of calcium throughout the
culture resulting in high deviations (Fig. 4.21 M). Similar, quantification of calcium
deposition on varying densities of collagen I coatings in ECIS wells reflect differences
seen during impedance measurements (Fig. 4.14) but are not significant (Fig. 4.21 M).
M N
ARS-quantification of coated wels ARS-quantification of colagen type I coated wels
A dCol1 - OIM B nCol1 - OIM C Col4 - OIM D FN - OIM E LN - OIM F PBS - OIM
G dCol1 - Ctrl H nCol1 - Ctrl I Col4 - Ctrl J FN - Ctrl K LN - Ctrl L PBS - Ctrl
Figure 4.21: Extracellular matrix molecules influence MSC differentiation: os-
teogenesis - Light microscopy of Alizarin Red S staining detecting calcium deposits of
osteogenic BMSCs on protein matrices (A-F) compared to not induced controls (G-K) af-
ter 21 days in culture; scale bar: 500 µm. (M) Quantification of alizarin staining shows
differences on osteogenic differentiation of BMSCs on protein coatings. (N) Osteogenic in-
duced cells compared to not induced cells on various concentrations of collagen 1 coatings
(5-50 µg/cm2) and uncoated control.
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Again, expression of adipogenic genes were also determined in RT-qPCR experiments
using the differentiation markers PPARγ, perilipin and adiponectin. While uncoated
control samples resembled the expression profiles of PPARγ and perilipin as seen be-
fore (compare Fig. 4.11), decreasing expression of those genes in adipogenic mainte-
nance medium (AMM), whereas high during induction cycle (AIM (Fig. 4.22 A and
B blue bars), on ECM protein coats this oscillating expression was only detected for
perilipin but not for PPARγ gene expression. After 14 days, also late adipogenic marker
adiponectin could be detected at high levels (Fig. 4.22 C). Although surprising weak
expression of adipogenic differentiation genes after 14 days for control samples compa-
rable with laminin coated samples was detected, highest levels of gene expression was
seen on fibronectin, followed by collagen I and somewhat weaker collagen IV, confirming
quantification data of ORO lipid staining (Fig. 4.19).
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Figure 4.22: Relative gene expression of adipogenic markers on ECM coatings
- Relative gene expression (induced minus uninduced) of adipogenic markers (A) PPARγ,
(B) perilipin and (C) adiponectin at different timepoints during differentiation process on
ECM proteins collagen I (green bars), collagen IV (orange), fibronectin (black), laminin
(white) and uncoated control (blue). After 3 days, induction medium was switched to
maintenance medium (black arrow) and back to AIM again (white arrow). All cells have
been analyzed at population doublings below 20.
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4.4 Cell migration monitored by impedance
To examine cell adhesion, migration and growth after wounding, cells were grown in
multi-wells with one single electrode and after reaching confluence cell layers were
wounded by a high voltage pulse resulting in a defined cell-free area surrounded by unaf-
fected living cells. Repopulation of the cell free-electrodes were monitored by impedance
recording.
4.4.1 Expression of adhesion molecule affects cell migration
Studying migration of keratinocytes into electrically wounded area further points on
effects of nidogen-1 on cell adhesion and therefore migratory properties, reflected by
prolonged recovery phase after wounding of nidogen-1 expressing keratinocytes com-
pared to not induced cells (Fig. 4.23 A). Similar negative effects of nidogen expression
on migration were also seen using mouse fibroblasts. Wild-type fibroblasts expressing
nidogen were slower compared to double knockout fibroblasts in which expression of
nidogen was abolished (Fig. 4.23 B).
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Figure 4.23: Wounding of HaCaT cells and fibroblasts - After reaching counfluency
HaCaT ND1 cells were exposed to high voltage pulses (4V, 3x 20s) and repopulation of
the electrodes was recorded. (A) Keratinocytes induced for nidogen-1 expression (green)
migrated slower compared to non-induced cells (red). (B) Similar migratory behavior
was observed in mouse fibroblasts. Repopulation of the electrodes took longer with wild-
type fibroblasts naturally expressing nidogens (green) when compared to fibroblasts which
lack nidogen-expression (red). Phasencontrast pictures of keratinocytes on electrodes (C)
before, (D) immediately, and (E) 3 hours after wounding, and (F) when electrodes where
fully repopulated after 10 hours; scale bar: 100 µm.
4.4.2 Migration of MSCs
Subjecting confluent BMSC (p6) cultures in the respective differentiation media to
electrical wounding generated impedance signals like during initial cell attachment with
flatter slope for adipogenic than for osteogenic cells (Fig. 4.24 A). For comparison,
cells were grown upon confluency separated by a silicon insert. After removal of the
separating wall, cells started to migrate into the gap to populate the cell-free area.
Closing of cell layer was documented by microscopy followed by picture analysis. Results
were similar to electrical wounding: adipogenic cells seem to be inhibited in growth and
migration when compared to osteogenic and control cells (Fig. 4.24 B).
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Figure 4.24: Migration of differentiating MSCs - BMSCs were seeded in differen-
tiation medium (adipogenic: blue, osteogenic: red, control: black). For wounding (A)
confluent cells were detached from electrodes by a 4V pulse (arrow), recording recovery by
growth of BMSCs over the electrode, impedance data are normalized to start value. (B)
BMSCs migration into the area of artificial gap from silicon inserts.
Furthermore, influence of single factors on MSC migration can be monitored by
impedance. Therefore, factors like SDF-1, PDGF and tumor necrosis factor (TNF)α,
which are closely related with MSC migration was monitored by electrical wounding
but also again by insert-based migration assays. While SDF-1 and PDGF did not show
significant differences to controls without additional factors, migration of cells treated
with TNFα was significantly delayed in both assays (Fig. 4.25).
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Figure 4.25: Migration factors influence on MSCs - BMSC in growth medium (black)
and supplemented with SDF-1 (green), PDGF (purple) and TNFα (orange) were detached
from electrodes by a 4V pulse (arrow), recording recovery by growth of BMSCs over the
electrode. (B) MSCs migrate into the area of artificial gap from silicon inserts.
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5 Discussion
Since their discovery, multipotent mesenchymal stromal cells (MSCs) have become at-
tractive candidates for the regeneration of soft and solid tissues and their reconstruction
in vitro by bioengineering. Thus, the ability of MSCs to differentiate ex vivo into multi-
ple lineages upon specific induction has been shown in numerous studies (Prockop, 1997;
Pittenger et al., 1999; Gregory et al., 2005; Nombela-Arrieta et al., 2011). Besides bone
marrow, other tissues, like adipose tissue, umbilical cord blood or umbilical cord matrix
were identified to harbor MSCs (Zuk et al., 2002; Bieback et al., 2004; Erices et al.,
2000) and isolates of MSCs underwent extensive comparative analysis of proliferation,
protein and gene expression, cell surface markers, or histochemical evaluation of their
differentiation potential (Baksh et al., 2007; Wagner et al., 2005; Shetty et al., 2010;
Banfi et al., 2000; Majumdar et al., 1998; Feldmann et al., 2005; Kern et al., 2006).
Although the ISCT has defined minimal criteria for MSCs (Dominici et al., 2006), an
unambiguous immunophenotype of MSCs can hardly be defined. Cell sorting of MSC
isolates is hampered by the complexity of surface markers and particularly low cell yields
due to the rare incidence of MSCs in tissue. Therefore descending from tissue isolates,
MSC are commonly separated from their haematopoietic counterparts simply by their
adhesive properties, resulting in mixtures of multipotent cells and progenitor or lineage
committed cells. Isolates of MSCs vary depending on the donor, the donor age and the
tissue MSCs originate from (Kretlow et al., 2008; Wagner et al., 2006), but also on the
method of isolation and in vitro cultivation. Furthermore, extensive expansion of MSCs
in vitro is often accompanied by the loss of differentiation potential (Kretlow et al.,
2008). Opposing in vitro ’aging’, maintenance of stemness is closely related to interac-
tions with the environment, en gros defining the stem cell niche, and therein the role of
cell interactions with the extracellular matrix (ECM) play a pivotal role (Volloch and
Kaplan, 2002; Mauney et al., 2004, 2006). While differentiation in several directions,
giving rise to osteogenic, adipogenic or chondrogenic lineages for example, has been
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successfully established for in vitro cultures of MSCs (Prockop, 1997; Pittenger et al.,
1999; Gregory et al., 2005; Nombela-Arrieta et al., 2011), the underlying mechanisms of
the inducing chemical factors are not fully understood, since in vivo cells are apparently
triggered by orchestration of many different stimuli. In addition, MSCs, transplanted
into certain body sites, are not immune to differentiate into irregular or pathological
tissue types (Breitbach et al., 2007) and occasionally MSCs have been also associated
with conversion into CAFs in tumor stroma (Galiè et al., 2008; Mishra et al., 2009).
Nevertheless, due to their versatile properties, ranging from immunosuppression and
tissue regeneration to trophic functions, MSCs are a promising source for cell therapy
(Sensebé et al., 2010; Zhao et al., 2010). However, this requires an improved under-
standing of how these cells maintain their stemness, how differentiation processes are
guided and the assessment of risks, e.g. for developing cancer. Last not least stan-
dardized procedures and good manufacturing practices (GMPs) have to be established
before broader usage of MSCs in regenerative medicine is indicated for safety and the
unambiguous benefit of the patients.
In this thesis the differentiation of MSCs from different sources has been investigated
in regard to specific inducing factors and cell-interactions with different ECM-molecules.
For this purpose, the novel method of non-invasive impedance measurements on living
cell layers was applied which allowed to monitor in real time early and late changes in
MSC cultures undergoing differentiation. MSC cultures have been analyzed according
to currently used clinical settings, being aware that they are heterogeneous mixtures of
multipotent to lineage-committed progenitor cells, and their progeny.
Changes in morphology and adhesion during MSC differentiation
Morphology and adhesion properties of different cell types vary depending on their in
vivo function. Thus, the overall cell-cell contacts of epithelial cells like keratinocytes
in vitro are stronger than cell-substratum or cell-matrix interactions, respectively, due
to the formation of high numbers of intercellular adherens and tight junctions and
especially desmosomes. The situation is inverse for cells derived from connective tissue
like fibroblasts or (multipotent) mesenchymal stromal cells. These cells secrete high
amounts of various ECM proteins and form strong interactions with the substratum
while direct cell-cell contacts are merely or not at all developed. These differences in cell
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morphology, cell-cell and cell-matrix interactions are utilized for impedance monitoring
of cell behavior.
For setting up the system, in a first round of experiments, cells of different cell types
were seeded at various densities and impedance profiles were recorded (see Fig. 4.1).
The impedance measurements showed over a wide range a strong correlation to cell
numbers for each cell type but revealed also marked differences between MSCs, skin
fibroblasts, and keratinocytes, underlining the effect of cell type-specific adhesion and
shape in concord with the predictions and assay principle.
Accordingly, cells in the process of differentiation are subjected to rearrangements
of cytoskeletal elements and adhesion structures both together leading to profound
changes in cell morphology and interactions according to their differentiation fate. In
order to explore this on multipotent stromal cells MSCs, isolated from bone marrow
or adipose tissue, were seeded at high densities in media directing distinct tracks of
differentiation or lacking inducing factors and impedance was recorded continuously.
Samples from different donors and tissues as well as in vitro aged cells were compared
and impedance profiles were correlated to the degree of differentiation, estimated by
histochemical staining, gene expression profiling, and protein analysis.
Adipogenic differentiation
MSCs induced for adipogenic or osteogenic differentiation yielded highly specific and
discriminatory impedance profiles. Shallower profile slopes in adipogenic medium (AIM)
in the initial phase indicated delayed cell spreading, i.e. slower or less intense forma-
tion of adhesion contacts than in the other media (see Fig. 4.5 A). The effect and the
responsiveness of cells became most apparent by following a cycling protocol for adi-
pogenic differentiation. The impedance steeply increased when adding the maintenance
medium AMM and promptly decreased upon switching again to AIM (Fig. 4.7). On the
molecular basis, this was paralleled by inverse PPARγ and perilipin expression (shown
by RT-qPCR; Fig. 4.11), which were determined at the corresponding time points.
This strongly argues for fluctuations in cell interactions, whereas effects due to massive
cell loss could also be excluded by counting nuclei positioned on the electrodes (Fig.
4.8). As a mechanistic explanation, IBMX and indomethacine in AIM reduces turnover
of cAMP and the increased cAMP activates PKA. The observed impact on the actin
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cytoskeleton may promote retraction of MSCs (Tio et al., 2010; Nombela-Arrieta et al.,
2011), but in addition the stimulated synthesis of hyaluronan and chondroitin sulfate
proteoglycan by activated PKA lowers cell contacts or widens spacing of cell-matrix
adhesion (Calvo et al., 1991; Zizola et al., 2007). Underlining these mechanisms, the ef-
fects on cytoskeleton and cell morphology were only marginal for MSCs in AIM lacking
IBMX or indomethacine, as judged by impedance recordings which rather resembled
profiles of uninduced MSCs (see Fig. 4.6). Thus, according to the profiles the lack of
the other inducing agents, dexamethasone and insulin did not affect adipogenic differ-
entiation per se, indicating a more supportive or enhancing role, e.g. by stimulating the
clonal amplification of committed cells.
The observed changes in cell morphology and cell-cell interactions during differen-
tiation are in total agreement with a very recently published study further elucidat-
ing impedance measurements of MSC differentiation (Bagnaninchi and Drummond,
2011). By applying a more sophisticated ECIS-system impedance values could be broken
down into their main contributing parameters of barrier resistance (Rb), cell membrane
capacitance (Cm) and cell-substrate parameter α (Giaever and Keese, 1991; Lo et al.,
1995; Bagnaninchi and Drummond, 2011). This uncovered definitely that the initial
increase in OIM after induction was more due to enhanced cell-substrate interactions
reflected by parameter α2 but differences to adipogenic-induced cells were diminished
over time. Supporting the here presented impedance data on fluctuations in cell inter-
actions during cycling adipogenic differentiation, Bagnaninchi and Drummond (2011)
demonstrated that after one day impedance was dominated by Rb values, reflecting the
established intercellular junctions. In AIM this value was almost zero but regained af-
ter medium change to maintenance medium presumably by reestablishing loose cell-cell
contacts due to changes in the cytoskeleton. This would explain why in AIM the MSCs
spread initially more slowly and acquired finally a roundish, adipocyte-like morphology.
The finally really advanced adipogenic stage was confirmed in these experimental
settings by intense ORO staining of lipid droplets, presence of ADRP and perilipin on
western blots, and expression of the late adipogenic marker gene adiponectin besides
PPARγ and perilipin. All those were detected by RT-qPCR in the MSC samples induced
for adipogenesis at the end points (Fig. 4.9 - 4.11).
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Osteogenic differentiation
The initially steeper osteogenic profiles reflect formation of strong cell adhesion, as
demonstrated by high cell-substrate parameter α (Bagnaninchi and Drummond, 2011).
Later on impedance is rising mostly due to firmly established intercellular junctions
but also enhanced ECM deposition by osteogenic cells which further increases layer
resistance Rb. This was confirmed by an additional report on higher impedance values
of MSCs in OIM (Hildebrandt et al., 2010; Bagnaninchi and Drummond, 2011).
In this work, differentiation was finally verified histologically by Alizarin red S or von
Kossa staining as well as detection of osteopontin and of late osteogenic marker BSP
on western blots at end points. In this context, it has to be emphasized that the initial
cell density matters tremendously when comparing results from different experimental
settings. Seeding MSCs at densities beyond confluency apparently saturates coverage of
the cell substratum or matrix support while also minimizing proliferation due to contact
inhibition, which is leading to signal saturation visible by impedance plateaus. Contrar-
ily, gain of impedance was much higher under conditions allowing to start with lower
number of MSCs (2.5 x 104 cells/cm2; xCELLigence system). Presumably both delayed
contact inhibition of proliferation and less restricted spreading contributed to steeper
impedance curves shown herein, a view supported by reports on enhanced expression of
adhesion receptors (e.g. integrins) in OIM (Mizuno et al., 2000; Warstat et al., 2010).
Underlining the value of this method, impedance curves clearly distinguished non-
differentiated from differentiating osteogenic or adipogenic cells and allowed a level of
quantification at early time points of differentiation (Fig. 4.7). This was true for high
passage versus low passage cells as well as for the comparison of MSCs from different
tissues or donors. Thus, comparing two MSC strains from adipose tissue, ASC-1 cells
showed in contrast to the fully potent ASC-2 cells merely a weak osteogenic impedance
profile (Fig. 4.7 C and D) which correlated to the at best marginal von Kossa staining
after 14 days (Fig. 4.9) and only a very faint osteopontin band on western blot.
Application of cells from different tissues
Up-to-now, only cells from bone marrow or adipose tissue were successfully used in
impedance-monitored differentiation experiments. Since cells from umbilical cord blood
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tested so far, showed distinct growth behavior, rather colony-like pattern than forming
confluent cell layers (not shown), no reliable impedance measurements for umbilical cord
blood cells was applicable. Therefore, the usage of impedance measurements has to be
tested for other cell sources than bone marrow or adipose tissue. Whether the height
or profile course of impedance can also be extrapolated to the degree of differentiation
potential has to be evaluated in future studies with larger sample cohorts and with
samples from various tissues.
As proof of principle for concept of impedance sensing even minutes changes due to
small molecular variations, a keratinocyte line (HaCaT cells), with inducible expression
was employed. These epidermal cells usually not expressing nidogen, could be forced
to express this adhesion molecule (present in BM) via doxycycline inducible vector. Se-
cretion of nidogen provided the cells increased adhesive properties, which were reflected
by impedance measurements (Fig. 4.3). Furthermore, like the induced HaCaT cells
also wild-type fibroblasts expressing genuine nidogen showed delayed repopulation of
the wounded electrodes compared to non-induced cells or nidogen-knock out fibroblasts
(Fig. 4.23). As a caveat, differences seen for fibroblasts should be considered with
some caution since those cells can vary from isolate to isolate and in addition undergo
changes during cultivation. Contrarily, the results of migration experiments with stable
HaCaT cell line, representing a rather homogeneous cell population, apparently just
evoked from their response to nidogen induction. Certainly, the molecular processes
in these manipulated nidogen-expressing keratinocytes need to be addressed in future
studies to elucidate the role of nidogen on changes in adhesion, cytoskeletal rearrange-
ments, and further consequences like delayed migration. Nevertheless, this emphasizes
the sensitivity of impedance measurement, being able to detect little changes caused on
the molecular level.
Migration of MSCs during differentiation
Differentiation finally leading to a basic change in cell functions, not only has a high
impact on morphology or adhesion of cells but also on their migratory behavior. Though
being one of the major characteristics of MSCs, their ability to differentiate into multiple
lineages might not be their major contribution to tissue repair in vivo. Rather than
being a source of new tissue or cell mass, there are cues that MSC contribution to
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tissue repair may largely occur through a more indirect, trophic functional manner.
Thus, upon recruitment to injured or inflammatory tissue MSCs secrete cytokines or
growth factors which stimulate resident stromal cells to proliferate and to secrete ECM
and other proteins, thus participating in or enhancing wound healing. But for this
scenario, first of all MSCs have to be either mobilized from their stem cell niche or
recruited from the blood flow to the wounded tissue, followed by final attachment and
homing there. To accomplish that, chemokines and growth factors are released from
inflammatory sites and distributed via the blood flow towards the stem cell niches
where they mobilize the MSCs (Ji et al., 2004; Sordi et al., 2005). The recruitment
of circulating MSCs to wound or inflammatory sites may occur by mechanisms shared
with lymphocytes, the elucidation of which will require further extensive research. To
study certain aspects of the migratory behavior of MSCs, cells were seeded at confluent
densities and repopulation of electrically wounded cell-free areas (high voltage pulse at
sensing electrode) was monitored by impedance recordings. Alternatively closing of an
artificial cell free area by surrounding MSCs was recorded at certain time points by
photomicrographs. Both showed distinct migratory behavior in response to initiation
of differentiation or to agents for stimulating cell migration (Fig. 4.24 and 4.25).
A key player in cell migration is RhoA, a member of the RhoGTPase family. It reg-
ulates the cross-linking of actin and myosin filaments into stress fibers and functions
in actin stabilization. RhoA also takes part in the formation of focal contacts by clus-
tering integrins and associated molecules, which are essential processes for migration,
too. Accordingly, inhibition of RhoA was leading to reduced MSC migration (Lee et al.,
2008; Raheja et al., 2011). In contrast, overstimulation with forced constitutively active
RhoA inhibited MSC migration (Jaganathan et al., 2007). While high levels of RhoA
correlated with osteogenic differentiation, the levels were lowered during adipogenesis
(McBeath et al., 2004). In turn this might contribute to decreased migratory properties
in adipogenic cells, in accord with the migration assays presented herein (Fig. 4.24).
For this test, the high seeding numbers gave rise to confluent cell layers which did not
reveal any significant variations in cell numbers in the different media as evaluated by
counting cell nuclei (Fig. 4.8). Therefore the number of cells surrounding the wound
area was very similar in all media and thus, the delay in wound recovery directly cor-
related to lower MSC migration in AIM (Fig. 4.24.The other way around, the impact
on the actin cytoskeleton, seen by fluorescence microscopy, accompanying adipogenic
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differentiation could be indirectly influenced by expression of RhoA, apart from regu-
lating cell migration. Lower migration of adipogenic cells compared to osteogenic or
undifferentiated cells replicates the in vivo situation. While there is no further need for
adipogenic cells to migrate within adipose tissue, the initial function of MSCs crucially
depends on migration towards injured tissue sites which could be also modulated by
ECM composition as discussed below. What osteogenesis is concerned, the continuous
turnover of bones relies on a fine-tuned interplay of osteoblasts and osteoclasts. Bone
matrix gets degraded by osteoclasts, followed by immigration of osteoblasts into the
degraded bone mass. The osteoblasts then rebuild bone structure by deposition and
reassembly of new organic and inorganic matrix material.
Low chemokinetic effects on MSC migration
To recruit cells, like MSCs, macrophages or neutrophils, for wound healing, chemokines
and cytokines but also specific growth factors are secreted from tissue cells at injured
or inflammatory sites in vivo. Several factors have been connected to the promotion of
MSC migration including SDF-1α, PDGF-AB, epidermal growth factor (EGF), insulin-
like growth factor-1, hepatocyte growth factor (HGF), interleukin (IL)-8, CCL5 (also
known as RANTES), monocyte chemotactic protein 1 (MCP-1) or vascular endothelial
growth factor (VEGF) (Ponte et al., 2007; Ringe et al., 2007; Spaeth et al., 2008).
However, the effects of the examined factors PDGF-AB or SDF-1α on migration were
quite low compared to standard growth medium (Fig. 4.25). This was in marked
contrast to previous studies claiming that these factors are highly potent inducers of
MSC migration (Ponte et al., 2007; Ringe et al., 2007; Ryu et al., 2010; Xu et al., 2010).
But in general, former studies have been performed in trans-well chambers, studying cell
migration towards a gradient of chemotactic agents. Contrarily, migration assays herein
were more likely to reflect chemokinetic or adhesion related effects on the cells apparently
hardly or not at all influenced by PDGF or SDF-1 (Fig. 4.25). Whether these factors act
on mobilization of MSCs from the stem cell niche or direct only circulating cells from the
peripheral blood has not been clarified yet. TNFα seems to act more indirectly on MSC
migration. It upregulates the expression of several chemokine receptors increasing the
response of MSCs to several factors and cytokines like CCL5 or TNF-related apoptosis-
inducing ligand (TRAIL) which increase cell migration (Corallini et al., 2010; Hemeda
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et al., 2010; Ponte et al., 2007). But the role of TNFα on adhesion molecules seems
to be of ambivalent nature. It increases expression of ICAM-1 which can activate
Rho-like GTPases and it interacts on actin organization, both being important players
in migration themselves (Fu et al., 2009). Contrarily, TNFα increased homing of rat
MSCs to cardiac microvascular endothelium which as shown to be mediated by VCAM-
1 (Segers et al., 2006). Therefore, the application of TNFα solely, without addition
of other chemokines might increase the adhesion of MSCs whereas Rho-like GTPase
activation is less efficient through TNFα leading to slower repopulation of ’wounded’,
cell free areas as indicated by the MSC migration assays herein (Fig. 4.25).
Results of MSC migration experiments in response to chemokine stimulation show
the limits of electric wounding assay. Since MSC migration is usually more towards a
gradient of chemokines, this assay is more dedicated to study adhesion-related effects
on migration and to identify involved receptors than to evaluate chemokine stimulation
of MSCs. However, studies with impedance measurements in transwell chamber ex-
periments are also under development or even already available and may facilitate the
analysis of chemokine-mediated migration and high-throughput screening of various
factors.
ECM proteins affect MSC differentiation
For studying the influence of specific cell-matrix interactions during differentiation, the
concept of monitoring MSC differentiation with impedance recording was extended:
Culture vessels were precoated with the ECM proteins collagen I, collagen IV, fi-
bronectin, or laminin before the cells were seeded and differentiation was initiated. For
MSCs, interactions with ECM proteins are crucial for the maintenance of their differ-
entiation potential in vitro (Mauney et al., 2005, 2006), which mirrors the role of ECM
in the stem cell niche or also for homing in target tissues. But ECM interactions can
also promote or inhibit distinct differentiation pathways (Mizuno et al., 2000; Mizuno
and Kuboki, 2001; Salasznyk et al., 2004; Mauney and Volloch, 2009, 2010), according
to some reports even without addition of specific inducing factors (Mizuno et al., 2000;
Klees et al., 2005). This is in line with herein presented findings that impedance val-
ues increased when inducing the osteogenic track in OIM on collagen I or IV coatings,
whereas the drop of profiles in AIM typical for adipogenic differentiation was far less
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pronounced (Fig. 4.12). Reduced adipogenesis on collagen matrix was confirmed by the
weak ORO staining after 21 days, whereas Alizarin Red S staining was more pronounced
on collagens (see Figs. 4.19 and 4.21). These data were in accordance with previous
reports on the effect of collagen I and IV on osteogenic and adipogenic differentiation
(Mauney and Volloch, 2009, 2010).
Applying collagen I in different densities, ranging from 0-50 µg/cm2 revealed only
marginal differences in ORO stain 5 days after adipogenic induction, whereas lipid
accumulation was lowered after 21 days at all collagen concentrations, supporting pre-
vious results of negative effects of collagen I on adipogenesis. Corresponding impedance
data in AIM or MSC-GM were more ambiguous, coating with 25 µg/cm2 showed high-
est impedance values in all media, likely reflecting best adhesion on this matrix (Fig.
4.14). Higher coating density using 50 µg/cm2 reversed this effect, showing surpris-
ing low impedance data, pointing to oversaturation of matrix coating and blocking of
cell adhesion sites instead of providing support. This is also reflected in OIM, were
impedance profiles are in sequential order to increasing collagen matrix density, ex-
empted 50 µg/cm2, and although not significant, the same tendencies were observed
by Alizarin Red S staining for calcium deposition. Overall this provides further evi-
dence for the hypothesis that increased adhesive properties which are reflected by high
impedance values might be supportive for osteogenic differentiation.
The situation is even more complex for fibronectin, which has been thought formerly
to be a negative effector of adipogenesis due to its strong cell spreading effect. But
this inhibition can be principally reversed by high insulin levels (Spiegelman and Ginty,
1983) as it is applied in our experiments by AIM. Apparently, fibronectin supported long
lasting spreading of MSCs reflected by the delayed decrease of impedance in the first
40 hours. Differentiation into adipogenic lineage was initiated afterwards, changing
morphology into round cell bodies over time and correlating to continuously declin-
ing impedance. For comparison, similar curves but lower impedance levels on laminin
inferred weaker adhesion as observed for other mesenchymal cells like fibroblasts. Prin-
cipally, the degree of cell adhesion and spreading is inversely related to adipogenic
differentiation where a more roundish cell shape is acquired which correlates with lipid
droplet accumulation (McBeath et al., 2004; Park et al., 2009). Interestingly, numbers
of ORO positive cells on fibronectin and laminin coats after 21 days of differentiation
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in AIM did not differ from uncoated controls, which presumably reflects deposition of
fibronectin or vitronectin from the FCS containing media as well as ECM secretion by
the MSCs themselves. The effect became even more striking by image analysis of the
average intensity of ORO staining which was markedly higher on fibronectin than on the
other matrices. Thus, fibronectin coating in our experiments did not prevent but rather
delayed adipogenic differentiation by increasing cell-substrate interactions, reflected by
an extended plateau and delayed drop of the impedance profile.
The degree of differentiation or its inhibition apparently depends, apart from possi-
ble concentration effects, on conformation or structure of protein coatings (Mauney and
Volloch, 2009, 2010). For those experiments, wells were coated with a film of native
ECM proteins and in addition for comparison of protein conformation with denatured
collagen I. Compared to its native counterpart denatured collagen I exhibits a more re-
laxed conformation, exposing other ’cryptic’ binding site for αvβ3 integrin while binding
sites for α1β1 and α2β1 integrins are masked (Davis, 1992). Altered adhesion proper-
ties match the impedance data of native versus denatured collagen I coating, while the
overall profile of the graphs on both conformations remained identical. But on the latter
matrix higher impedance values were noted in all media, which argues for increased ad-
hesion of MSCs on denatured collagen I in general (see Fig. 4.15). As already discussed
above, increased adhesion is related to a decrease in adipogenesis and improved osteo-
genesis, as confirmed by lipid and calcium staining, respectively. However, these results
are in contrast to a previous study, claiming efficient p38 kinase regulated adipogenesis
but inefficient osteogenesis in a Hsp90-independent manner on denatured collagen I.
One explanation of this discrepancy be a harsher treatment for collagen denaturation
in that study, possibly leading to molecular damage and a gelatin like material with
adverse properties. The finding of an inverse relation on native collagen I by the au-
thors (Mauney and Volloch, 2009) is in line with the data for native collagen I presented
above. Also in harmony with the results on collagen IV Mauney and Volloch (2010)
found a negative influence of native collagen IV on adipogenesis, though it was again
highly efficient on denatured collagen IV matrices.
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Requirements for cell therapies with MSCs
The herein presented results support former findings of varying potential of MSC isolates
and underline the regulatory role of cell-matrix contacts for maintenance of stemness
and differentiation processes. Thus, to generate more homogeneous, standardized MSC
populations for research and therapeutic application, methods for MSC isolation and
conditions for in vitro cultivation need to be optimized and better standardized. This
also implicates the general need for the development of GMPs. On the one hand, op-
timized media and a growth environment for the maintenance of stem cell properties
like self-renewal and differentiation potential are required, which on the other hand
the development of culture conditions for most efficient lineage commitment and dif-
ferentiation, e.g. for cell replacement therapies, are desirable. Therein, the quality
of cultivation medium plays a pivotal role. Although in vitro propagated, autologous
MSCs do not provoke alloreactivity themselves after in vivo transplantation, some re-
cipients of MSCs formed antibodies against FCS, a common supplement of standard
media for ex vivo culturing of cells (Sundin et al., 2007), which might provoke side-
effects in patients. This underlines the necessity to optimize and standardize in vitro
cultivation, which ensures MSC functionality without bearing biohazards. Chemically
defined media, human AB serum or thrombin-activated platelet-rich plasma as alterna-
tives to FCS supplemented media, are currently under investigation (Kocaoemer et al.,
2007) and will gain importance in future MSC research and especially for cell therapy.
Herein, impedance based assays can not only be used for studying proliferation, but
furthermore impedance can help to assess the impact of distinct media on stemness and
differentiation potential. As far as shown in this thesis, the fate of MSCs - maintenance
of stemness, tissue homing and differentiation - also depends on extracellular matrix
contacts. Structured coating with RGD peptide, generating a pattern with defined
molecular spacing has demonstrated that this governs outside-in signaling through the
integrins bound to these ligands which can have dramatic consequences for cellular fate
(Selhuber-Unkel et al., 2010). Future experiments with combinations of varying proteins
of the ECM or with bioactive peptides and synthetic compounds will help to identify
receptor molecules to correlate impedance profiles with patterns of cell receptors re-
sponsible for maintenance of stemness or guiding MSC differentiation. Identification of
these receptors, e.g. by blocking with specific antibodies or RNAi techniques, will not
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only improve the definition of the stem cell niche but also provide information how cells
maintain vitality and their properties while traveling in the circulation. For that goal
mimicking of more in vivo-like conditions is required. Thus, more complex ECM scaf-
folds, MSC growth and differentiation in three-dimensional cultures or cultivation under
hypoxic conditions need to be tested and which may provide new insights especially into
cell-matrix interactions.
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Conclusions
In this work the behavior and differentiation potential of multipotent mesenchymal
stromal cells (MSCs) have been investigated in response to inducing agents and un-
der particular consideration of cell adhesion and cell-matrix interactions. For this task
monitoring live cells by electrical cell impedance sensing (ECIS) was adapted and op-
timized, verifying the tracks of adipogenic or osteogenic differentiation by light mi-
croscopy, analysis of gene expression and marker proteins as well as histological and
fluorescence staining. Establishing this continuous real-time and non-invasive method
with different cell types clearly showed distinct impedance profiles closely correlating
to cell numbers in general and specifically adhesive properties of the various cells types
which were changing according to the specific differentiation modes as shown herein
in great detail for MSCs. Furthermore, according to those ECIS recordings a marked
variation of differentiation potential has been found depending on donors, tissue of ori-
gin and number of cell passages in vitro confirming former findings by other methods
(Sekiya et al., 2002; Bonab et al., 2006; Kretlow et al., 2008).
During differentiation MSCs change, together with function and morphology, their
contacts with neighboring cells and matrix proteins both of which adding to the fate of
MSCs in return. As shown herein, osteogenesis is favored on collagen matrices, while fi-
bronectin was promoting adipogenic differentiation in vitro, an issue under controversial
debate in the past. Corresponding to overall changes in expression of genes and proteins
in each stage of differentiation, patterns of matrix receptor molecules, largely integrins,
undergo profound alterations. These cell-matrix interactions trigger further signaling
pathways (outside-in signaling) which in turn contribute to differentiation modes and
cell behavior in general. Identification of these receptors and the changes within recep-
tor expression is essential to gain new information on the mechanism involved in homing
of MSCs at specific tissue sites or stem cell niches, including the maintenance of stem-
ness and guidance of differentiation. The fact that also very early changes with onset of
MSC differentiation are detectable by impedance measurements, which can neither be
addressed reliably by histochemistry nor by profiling of gene expression or cell surface
markers, recommends this method for further research on these processes involving cell
attachment and specific interactions. A better understanding of the underlying cell
biology will certainly boost therapeutic applications.
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However, for treatment of patients in particular but also to make research results
of MSC preparations better comparable, methods for isolation and in vitro cultivation
have to be further optimized and standardized, generally implied in the development
of good manufacturing practices (GMPs). This emphasizes the importance of specific
cell isolation procedures and especially directed amplification (e.g. by cell-matrix inter-
actions) with regard to maintenance or lineage commitment of the cells before broader
application in research or clinical trials. For this purpose impedance sensing qualifies
as particularly suitable quality control for the screening of larger MSC sample cohorts,
which can also be combined with microscopy directly or in parallel applying advanced
imaging techniques.
In this thesis the impedance measurements have been demonstrated to represent a
non-invasive real time technique for monitoring early steps in cell attachment and fur-
ther interactions and the fate of MSCs. Based on the stability of the method to clearly
discriminate MSCs from other cell types and to display typical profiles of osteo- and
adipogenic differentiation, this method may be considered as a valuable tool for screen-
ing large panels of inducing factors or support matrices, but last not least for quality
control of MSC preparations. This work should also provide a basis for future inves-
tigations on adhesion related cell behavior and identification of receptors contributing
to the intracellular signaling, analyzing these processes in a label-free and continuous,
non-invasive manner.
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